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Abstract: Purpose
Persistent physical symptoms (PPS) are often associated with profound physical
disability and psychological distress. Interventions for PPS that promote behavioural
change, aim to reduce levels of symptoms and improve overall functioning in patients.
The evidence for these interventions is mixed, with effective relationships between
patients and health practitioners (HP) reported as the key to the success of primary
care interventions. The objectives of this systematic review were to synthesise the
qualitative evidence and to evaluate the acceptability of behavioural interventions for
PPS in primary care, from the perspective of both patients and HPs. Methods: A
comprehensive literature search was conducted in 7 major electronic bibliographic
databases, to February 2019. The aim was to identify a broad range of literature
including, qualitative research, mixed methods research, qualitative data embedded in
trial reports or process evaluations. 58 full papers were screened against the inclusion
criteria. Nine studies were included and quality assessed. A qualitative evidence
synthesis was conducted using thematic synthesis. Results: Some patients and HPs
reported positive gains from taking part in or delivering interventions, with appropriate
support and explanation of their symptoms important for patients. Barriers appeared to
be underpinned by the relationship between the patients and HPs, and by beliefs and
attitudes held by both parties. Conclusions: Patients should be provided with adequate
information to make an informed decision about whether an intervention is appropriate
for them, and interventions should not end suddenly, or without adequate follow-up.
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HPs should receive training and supervision to address their lack of confidence, and
improve their knowledge of PPS.
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"The Acceptability of Primary Care or Community-Based Behavioural Interventions for Persistent Physical Symptoms: Qualitative Systematic Review" 
Dear Editor and reviewer,  
Many thanks for taking the time comment on our revised manuscript. The suggestions for changes to the manuscript have been transposed in the table below, 
together with information about how we have addressed these points and revised the manuscript accordingly. We very much hope they are to your 
satisfaction. 
Reviewer #2: Author response 
First, I'm not sure if the abstract I was viewing at the very top of 
the resubmission was the version with edits made. If this is the 
updated abstract, it doesn't match the edits described in the 
response toe reviewers table, e.g. the second sentence. 
Apologies, this was an oversight. This has been corrected to ensure the changes match. 
Second and final, although the Discussion provides a lot more 
detail e.g. related to implications, there is an element missing, and 
I think it has to do with details of the primary care context when it 
comes to putting future interventions into place. The authors made 
it clear in this version why the focus is on primary care, and has 
provided very practical and clear guidance for research and 
practice, based on the evidence reviewed. However, the setting of 
primary care is just so complex, and I think that should be 
addressed alongside the discussion of the findings. The authors 
might also add some details about what's next for the findings of 
the review in the context of their wider project. 
Many thanks for your comments. We have added the following to the discussion section, and 
hope they adequately answer your point; 
‘As the review showed, there are a number of ways interventions can be delivered in primary 
care, and therefore the complexity of the primary care setting should also be considered and 
acknowledged in the development of new interventions. The settings covered here included 
GPs delivering interventions to their own patients, or coordinating care of another HP, and 
where the intervention might take place away from a GP practice but not in secondary care. 
Although, it is difficult to make specific recommendations about which type of primary care 
setting is optimal, there is a perceived importance to some involvement with primary care 
rather than being referred directly to secondary care, with patients valuing working with HPs 
that they know and are aware of their circumstances.’ 
 
‘These findings, together with the findings of the wider report which also included a 
quantitative evidence synthesis and economic modelling, has identified research 
recommendations for primary research in this important area affecting a large number of 
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Statement of Contribution 
What is already known on this subject?  
 Evidence for interventions for PPS that aim to promote behavioural change is mixed, with 
some showing positive results and others unable to draw conclusions on effectiveness. 
 The relationship between patients and service providers is reported as key to the success of 
interventions, with poor communication between parties, and lack of emotional and practical 
support suggested barriers to effective intervention.  
 
What does this study add?  
 Patients valued being supported and being provided with explanations for their symptoms. 
 Training for health professionals was thought to be helpful and may address barriers. 






Persistent physical symptoms ‘PPS’ is a portfolio term covering a wide range of 
presentations in referring to persistent bodily complaints, including pain and discomfort. 
PPS are often associated with psychological distress and functional impairment 
(Dirkzwager & Verhaak, 2007). The term has also been applied to patients presenting 
with chronic fatigue syndrome, also termed myalgic encephalomyelitis (CFS/ME); 
irritable bowel syndrome (IBS); or fibromyalgia, which are usually referred to as 
functional somatic syndromes (FSS) (Wessely et al., 1999). The term PPS is used in this 
paper rather than medically unexplained symptoms (MUS). The term MUS is 
controversial, and debate regarding its use is on-going. For many patients with 
symptoms that are not, in the current state of medical knowledge, readily explicable by 
organic disease, a diagnostic label is important.  However, the label ‘medically 
unexplained symptoms’ can be regarded as offensive (Stone et al., 2002), and it has 
been suggested that the use of the term is a barrier to improved care (Creed et al.2010). 
Results of an online survey of healthy adults demonstrated that the most popular term to 
refer to persistent bodily complaints, including pain and discomfort, was PPS, and was 
more acceptable than the term MUS (Marks & Hunter (2015). A further study 
(Picariello et al., 2015) demonstrated that patients with CFS preferred the term PPS to 
describe their own condition, and also illnesses such as IBS and non-cardiac chest pain. 
Whilst we have used the term PPS in this paper, previous academic literature has 
generally used the term MUS, therefore it was necessary to use that term whilst 
conducting our literature searches, and we have kept references to MUS in this paper 
where appropriate in order to accurately report these previous findings.   
 
Main document (incl. figs and tables)
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Diagnostic criteria for PPS are varied and patients visiting their GP frequently with 
unexplained symptoms are not necessarily offered a formal diagnosis. In the UK, Taylor 
et al. (2012) report a prevalence rate of 18% in consecutive attenders to UK GP 
practices. Worldwide prevalence rates of primary care patients presenting with PPS 
have been reported as between 25% and 50% (Edwards et al., 2010). It has been 
estimated that 50-75% of patients with PPS will improve, whilst between 10% and 30% 
will see their condition deteriorate (Olde Hartman et al., 2009). However, a recent study 
has reported that only 11% of UK primary care patients had recovered at 6 months and 
55% were still having persistent symptoms (Lamahewa et al., 2019). 
 
Generally, interventions offered for PPS, across a variety of health settings, are based 
around pharmacological, psychological, or physical therapeutic models. 
Pharmacological interventions have been shown to produce some improvement in 
patients in terms of symptom severity and functioning (Kroenke, 2007, Hoedeman et 
al., 2010, Ford et al., 2009), although with significant heterogeneity of efficacy between 
different FSS.  
 
The evidence for interventions that aim to promote cognitive, emotional and/or 
behavioural change is mixed, with cognitive behaviour therapy (CBT) appearing to 
have the most consistent evidence. CBT for PPS is based on the broader model which 
suggests an acute event such as injury or infection precipitates the symptoms which are 
then perpetuated though an interaction of cognitive, behavioural, emotional and 
physiological factors. CBT and behavioural based therapies aim to alter one or more of 
these factors to reduce the severity and/or impact of the symptoms. For instance, worry 
about symptoms can heighten autonomic nervous responses and sensitisation to 
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symptoms.  Prolonged periods of inactivity due to the fear that activity is harmful, may 
impact sleep and muscle integrity and exacerbate symptoms such as pain and fatigue. 
For fibromyalgia, CBT has been shown to improve physical symptoms and functioning 
(Arnold et al., 2012), as have exercise therapies (Marcus, 2009, Busch et al., 2007). A 
recent network meta-analysis of the psychological interventions for IBS concluded CBT 
and gut-directed hypnotherapy had the largest evidence base and were the most 
effective at reducing the severity of IBS long term (Black et al., 2020). However, the 
authors noted that there was significant heterogeneity between studies and issues 
regarding trial design, including lack of blinding, which may mean treatment effects 
were overestimated. A 24 month follow up of the largest CBT trial for IBS to date 
showed that effects were largely at sustained at 24 month follow up compared to usual 
care (Everitt et al., 2019). A Cochrane review of CBT for CFS (Price et al., 2018), 
concluded CBT was more effective at reducing fatigue at the end of treatment than 
usual care and wait list control as well as other therapies such as relational counselling.  
The data for longer term follow-up was more mixed.  The review also concluded that 
there was a paucity of studies on the acceptability and possible side effects of CBT.    
 
General practitioners (GPs) play a major role in identifying and managing patients with 
PPS. Most patients with PPS will be seen initially in primary care, often for many 
consultations, prior to referral to secondary care, or less often specialist services. 
However, the majority of the research in this patient group has been conducted in 
secondary care with less evidence specific to the primary care setting. The relationship 
between patients and service providers has been reported as key to the success of 
primary care interventions in PPS in a number of studies (Smith et al 2003, Heijmans et 
al., 2011; Gask et al., 2011). Poor communication between GPs and patients during 
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medical consultations, and lack of emotional and practical support are suggested 
barriers to effective recognition and treatment of PPS (Murray et al., 2016). These 
barriers may limit opportunities to explore contributing factors and appropriate 
interventions. Creating a safe, therapeutic environment, and offering effective 
reassurance, are important enabling factors (Heijmans et al., 2011), thus highlighting the 
need for acceptability of interventions for both patients and health care practitioners.  
 
This is the first qualitative systematic review, to our knowledge, to specifically explore 
the acceptability of behavioural interventions for diverse PPS populations based in 
primary care, including patients meeting the criteria for MUS, Medically Unexplained 
Physical Symptoms (MUPS), and somatoform disorders, and including populations 
with specific FSS, e.g. IBS, CFS, fibromyalgia. Previous qualitative systematic reviews 
have only examined patients’ experiences more generally, in terms of how patients, 
family and the medical community interpret the illness, not relating to experiences of 
undertaking behavioural interventions (Anderson et al., 2012). The objectives of this 
study were; to synthesise evidence relating to the barriers and facilitators of the 
acceptability of primary care or community-based behavioural interventions for 
Persistent Physical Symptoms, in the UK, from the perspective of both patients and 
service providers, by undertaking a comprehensive systematic review of the available 
qualitative research literature, using rigorous methods for review and evidence 
synthesis. 
Methods 




The search methods sought to identify evidence in the form of qualitative research, 
qualitative data reported in mixed methods research, and qualitative data embedded in 
trial reports or process evaluations. A systematic search strategy was developed by a 
library information specialist (ASu) to identify this evidence relating to a primary care 
or community-based population; population terms were combined with terms that 
define the setting. Published methodological search filters to limit results to qualitative 
studies were used where available (ISSG, 2019), and was combined with a geographic 
filter to identify UK studies only.  No other search limits were applied. Initial search 
results therefore covered the period from 1980 to July 2016, updated in February 2019, 
in 7 electronic databases including MEDLINE, Embase, CINAHL, PsycINFO, Science 
Citation Index, and Social Sciences Citation Index . Citation searching and reference list 
searching, were also undertaken to identify any further citations that may not have 
appeared in electronic databases. (see supporting materials for further information). 
Screening and eligibility 
Titles and abstracts of all citations retrieved through the searches were scrutinised by 
one systematic reviewer (ASc) according to the inclusion and exclusion criteria (Table 
1.).  Agreement on inclusion at title/abstract sift was checked by a second systematic 
reviewer (AB) for 20% of the total electronic search results. Agreement was calculated 
using the Kappa statistic. Given a Kappa statistic of 0.77, (i.e. above recognised 
acceptable levels (0.7)) double sifting was not deemed necessary. All full texts were 
considered for inclusion by two reviewers (ASc & AB). Disagreements on study 
inclusion were resolved with reference to a third reviewer (JL).   
Table 1. Inclusion and exclusion criteria. – about here 
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Quality assessment strategy 
Inclusion criteria for study design were broad, with any study presenting qualitative 
evidence being eligible. Therefore, a study quality checklist for qualitative studies was 
developed prior to study screening (using an adapted form of the CASP checklist for 
qualitative research), to allow flexibility in accommodating findings from studies with 
research designs that were not primarily qualitative in nature (see table 2).  No studies 
were excluded on the basis of quality (Carroll & Booth, 2015).  
 
Table 2.  The Quality Assessment Questions applied to included studies – about 
here 
Quality constituted one aspect of the assessment of the confidence of findings from the 
included studies, using CERQual as described below in the methods of synthesis 
section. 
Data extraction strategy 
Data extraction was undertaken by one reviewer (ASc) using a data extraction tool 
tailored for the purpose of this review. All data extractions were checked by a second 
reviewer (AB), with discrepancies discussed by both reviewers. Given the anticipated 
paucity of relevant evidence, an inclusive approach to data extraction was employed in 
which all qualitative data identified in the primary studies and relevant to the review 
question was extracted (Noyes and Lewin, 2011). The framework for extraction allowed 
data from the primary studies to be extracted verbatim into general categories relating to 
the review question, directly from the papers, as illustrated in Table 3 below. This 
allowed familiarisation with the data and was akin to assigning preliminary codes to the 
data, which described the content. 
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Table 3. Framework for data extraction – about here 
Data Synthesis Strategy 
Thematic synthesis was used to aggregate the data (Thomas & Harden, 2008). Themes 
were developed within the data extraction elements (table 3). Specifically, one reviewer 
(ASc) went through the data assigning preliminary codes line by line according to its 
meaning and content. These codes were then organised and grouped together to become 
sub themes, which were largely descriptive, and which were later grouped into over-
arching themes, which were more ‘analytical’. Line by line coding allowed the 
translation of concepts from one study to another; as each study was coded new data 
were added to existing codes, and new codes were developed as necessary. These sub 
themes remained very close to the original findings, whilst the over-arching themes 
went beyond the findings of the original study to suggest new understandings, based on 
the judgement and insights of the reviewers.  
The Confidence in the Evidence from Reviews of Qualitative research (GRADE-
CERQual) (Lewin et al., 2015) approach was used to summarise confidence in findings 
from included studies. CERQual assesses confidence in synthesised review findings 
based on the four key components of methodological limitations, adequacy, coherence 
and relevance. Confidence in each review finding was judged as high, moderate, low, or 
very low, as defined according to the CERQual approach (see supporting information 
for further definition).   
Results 
From the 2119 citations identified from the searches, 58 remained after title and abstract 
sift, and were considered at full paper sift. Twelve full papers reporting evidence from 
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nine studies were included in the review.  Figure 1 shows the PRISMA flow chart of 
studies included in the qualitative review. All included full papers were published 
between 2007 and 2018. 
 
Figure 1: PRISMA Flow Diagram– about here 
Study respondents 
Eight studies provided evidence about patients’ attitudes and four studies provided 
evidence about HP attitudes to the intervention. Overall, the studies contained 
qualitative data from 130 patients, and from 48 HPs. HP data were derived specifically 
from 24 general practitioners (GPs), 10 physiotherapists, 8 CBT therapists, 3 Nurse 
therapists, and 3 nurse therapist supervisors (see Table 4). 
 
Table 4 Summary of the included studies and their sample and study 
characteristics – about here 
  
Respondent characteristics 
Six studies focused on interventions for MUS/MUPS, one for CFS/ME, one for Non-
specific chronic low back pain and one defined as for somatisation, where all patients 
included in the study were described as presenting with physical symptoms that were 
medically unexplained. Of the 130 patients taking part in the included studies most 
patient participants met the criteria for MUS or MUPS (n=84) with the remaining 46 
patients diagnosed with CFS/ME. Reporting of participant characteristics was limited 
and incomplete in several studies.  Details where reported are shown in Tables 5 and 6 
below.   
9 
 
Table 5 Summary of patient characteristics – about here 
 
Table 6 Summary of health practitioner characteristics – about here 
Intervention description and facilitators 
Three interventions were delivered by GPs (Peters et al., 2009; Dowrick et al., 2008; 
Burton et al., 2012; Morton et al., 2016), one by nurse-therapists in a single study 
(Chew Graham et al., 2011; Peters et al., 2011), and one by physiotherapists in a single 
study (Cowell et al., 2018a; Cowell et al., 2018b). Trained CBT therapists delivered one 
intervention investigated in two studies (Gerskowitch et al., 2015; Lewis et al., 2013). A 
psychological well-being practitioner (PWP) delivered a low intensity CBT intervention 
and a trained facilitator delivered a mindfulness-based stress reduction (MBSR) 
intervention in one of these studies (Gerskowitch et al., 2015). Group counselling 
(humanistic) was facilitated by a ‘group counsellor’ (Graham, 2007), and the BodyMind 
Approach intervention was delivered by clinical psychologists together with facilitators 
who were psychotherapists or art therapists (Payne et al., 2015).  Most interventions 
were delivered individually to patients; however, three interventions were delivered in a 
group setting, i.e. MBSR, humanistic counselling, and the BodyMind approach 
(Gerskowitch et al., 2015; Graham, 2007 & Payne et al., 2015). (see table 7)   
 
Table 7 Description of the interventions delivered in the included studies – about 
here 
 
Quality of the included studies 
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Results of the quality assessment for each study are presented in Table 8. The quality 
levels to be applied to the evidence, high, moderate or low were chosen to be 
conservative. The reviewing team made a judgement that a study must meet all criteria 
to be regarded as high quality. If any criterion was not fulfilled the study was regarded 
as moderate quality. However if more than one criterion had not been achieved it was 
concluded that it was not possible to assess the study as high or moderate quality. 
 
Table 8 Quality assessment results for the included studies. – about here 
 
Certainty of the review findings – CERQual assessment 
The CERQual approach utilised the methodological quality of each study contributing 
to the review finding.  Relevance was assessed by considering the format of the 
intervention, (whether individual or group based), and the facilitator, (whether a GP, 
nurse therapist, or psychological therapist). Given that the inclusion criteria specified a 
primary care- or community-based setting, this criterion was not considered in the 
analysis of relevance. Coherence was assessed by considering if all the data contributing 
to a finding supported that finding and the presence of ambiguities or plausible 
alternative explanations.  Finally, adequacy was assessed by considering the richness 
and quantity of data supporting each review finding.  The synthesis of evidence from 
patients yielded 22 review findings.  Only one finding was assessed as high confidence, 
six findings were assessed as moderate confidence, 13 were assessed as low confidence 
and two as very low confidence.  The evidence from HPs yielded 16 findings overall.  
Four findings were assessed as high confidence, eight as moderate confidence, and four 
as low confidence. (The results of the CERQual assessment are set out alongside each 




Synthesis of patient and health practitioner evidence 
Data were synthesised across all intervention types and organised according to the 
questions outlined in the data extraction framework (table 2). Each theme and sub-
theme, together with evidence from the primary studies and an estimate of the strength 
of the evidence are presented within the following narrative synthesis, and also in Table 
S1 and Table S2 (supporting materials).  
 
Factors identified as important in interventions for PPS from the perspective of 
patients who had received the interventions 
Support 
Feeling supported was defined by patients as being accepted and validated by the HPs, 
receiving empathy, and being listened to.  This need for support was identified across 
diverse intervention types with high confidence in this finding (Gerskowitch et al., 2015; 
Chew-Graham et al., 2011; Graham, 2007; Morton et al., 2016; Peters et al., 2009; Peters 
et al., 2011; Payne et al.; 2015). Such support was described as the most positive part of 
the pragmatic rehabilitation intervention in one study, with ‘being believed and feeling 
understood by the therapist’ identified as a key part of the intervention (Chew-Graham et 
al., 2011).  Patients across various intervention types reported being validated by the HP 
as important (Chew-Graham et al., 2011; Gerskowitch et al., 2015).  This feeling was 
sometimes due to the knowledge the HP had of the patient’s symptoms giving them a 
sense of having someone ‘on their side’ (Gerskowitch et al., 2015; Morton et al., 2016; 
Peters et al., 2009).  In some instances, it appeared that no one else in their lives was able 
to provide such support, ‘It was just an understanding from her that I didn’t, haven’t had 
from anybody else’ (Patient, Chew-Graham et al., 2011). One patient reporting that the 
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empathetic nature of the nurse delivering the supportive listening intervention was their 
most valued attribute (Peters et al., 2011). 
 
The feeling of being understood also came from fellow participants with similar 
symptoms within group interventions (Gerskowitch et al., 2015; Graham et al., 2007; 
Payne et al., 2015).  These factors were reported as key to patient engagement and 
contributed to whether the interventions were reported as acceptable to the participants 
(Chew-Graham et al., 2011).   
 
Explanation 
Patients valued explanations of their symptoms which they had been provided with as 
part of the interventions. They reported that this led to their acceptance and understanding 
of the treatment model, both for a CBT for MUPS study (Gerskowitch et al., 2015) and a 
pragmatic rehabilitation for CFS study (Chew-Graham et al., 2011), with moderate 
confidence assessed in this finding.  They also felt that the pragmatic rehabilitation 
intervention helped them to come to terms with and accept a diagnosis (of CFS) and that 
having an explanation and understanding of their symptoms was key to this. ‘She 
explained all about CFS and the physiology of it really, which was the first time really 
that I understood why my energy was so low, so that made a lot of sense.’ (Patient, Chew-
Graham et al., 2011). Gaining new knowledge about their symptoms was reported to be 
reassuring to patients enabling them to make an initial judgement about whether the 
intervention might be appropriate for them (Chew-Graham et al., 2011).  Patients reported 
that they consulted their GP in order to seek an explanation for their symptoms (Peters et 
al., 2009), and took part in interventions to see someone who had specialist knowledge 




Important factors for the delivery and success of interventions from the 
perspective of patients 
With interventions where behavioural self-management techniques were taught, some 
patients reported they had benefited from these. This was evidenced across four of the 
studies which included the following interventions; CBT for MUPS, Mindfulness, 
group counselling, GP with a special interest ‘symptoms’ clinic and the BodyMind 
approach intervention. Participants commented on their improved confidence 
(Gerskowitch et al., 2015; Graham, 2007; Morton et al., 2016; Payne et al., 2015) and 
improved communication with significant others, ‘I have spoken to friends about my 
feelings and hold fewer grudges.’ (Patient, Graham, 2007). Specific to group 
interventions patients found sharing their experiences with other patients, (Gerskowitch 
et al., 2015) and learning skills from other patients (Gerskowitch et al., 2015; Graham, 
2007) valuable as part of the intervention. 
 
Patients reported needing reassurance and a good relationship with the person delivering 
the intervention (Peters et al., 2009). Patients involved in a reattribution intervention 
liked having a longstanding relationship with the GP, and this gave giving them a 
feeling that the HP would know what type of treatment, if any, would be suitable for 
them, ‘He knows I like to keep myself to myself, knows I believe in self-help...knows I’m 
somebody that likes to work it out for myself’. (Patient, Peters et al., 2009). Others 
appreciated the understanding and reassurance they received from the HP and just 




Important factors for the delivery and success of interventions from the 
perspective of health practitioners 
Across four studies, and with high confidence in this finding, HPs reported positive 
factors around extending their own knowledge and skill. They reported training and 
supervision in applying behavioural interventions as helpful, and developed their 
knowledge and skills in the area of PPS (Peters et al., 2011; Dowrick et al., 2008; Cowell 
et al., 2018a; Cowell et al., 2018b). Training helped them to learn about the boundaries 
of their own role (Peters et al., 2011), and to be flexible when delivering interventions 
(Peters et al., 2011; Lewis et al., 2013). In one study, some GPs reported that reattribution 
training increased their confidence in discussing PPS, and to reflect on management 
decisions, ‘I'd like to think that I do go a little bit more into other agendas, other issues 
that might be fuelling the symptoms that they've got and try and approach those other 
problems rather than just focusing on a prescription for something for pain’ (GP, 
Dowrick et al., 2008). 
 
In three studies, contributing to a finding of high confidence, (Lewis et al., 2013; Peters 
et al., 2011; Cowell, 2018a; Cowell, 2018b) HPs reported that it can be rewarding when 
it is evident that patients have gained benefit from the intervention. ’And it was like 
watering a flower it was really lovely for me personally... it was lovely watching her just 
blossom, you know what I mean, because she finally took on board the physical stuff and 
the sleep.’ (Nurse, Peters et al., 2011) 
 
The primary care or community setting was reported to be a helpful factor by the HPs in 
two studies.  In one study the reason for this was that the primary care setting allowed for 
a more tailored approach, or that the setting, such as being in patients homes, was useful 
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when trying to develop a therapeutic relationship (Peters et al., 2011).  In another case 
this contrasted with the perceived potential failing of the secondary care setting (Dowrick 
et al., 2008). ‘You see these people getting referred to the hospital with back pain and the 
next thing you know some bright spark is going to operate on them and you think 
‘What!’….Maybe we’re here in a way as a gateway to try and prevent harm as well as 
anything else.’ (GP; Dowrick et al., 2008). This appears to indicate that primary care 
practitioners see part of their role as protecting their patient from entering secondary care 
where they believed this was unnecessary.   
 
Factors identified as barriers to intervention success by patients 
Patients reported a feeling of scepticism toward HPs, with data contributing to this finding 
across four studies with moderate confidence. This included the concern that mentioning 
psychosocial problems would divert GP attention away from other physical problems 
associated with their symptoms (Peters et al., 2009), and in one study, patients had the 
feeling that the aim of the GP was to assert their problems were psychological (Burton, 
et al. 2012). Patients also reported being concerned that they would only be provided with 
simplistic explanations for their symptoms, as in a study of CBT for MUPS delivered by 
CBT therapists (Gerskowitch et al., 2015). 
  
Patients reported that the lack of information given to them by those that referred them to 
the study meant that they did not know the remit of the intervention, and that the referring 
GP also often did not know what the intervention entailed.  Patients were therefore 
surprised by the content of the intervention and found it difficult to see why they had been 
referred to a psychological therapy-based intervention when they perceived their 
problems as physical (Gerskowitch et al., 2015). There was also a feeling from patients 
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in two studies, that some HPs, GPs and nurse-therapists, were unskilled or lacked the 
knowledge to deal with their symptoms or provide an appropriate intervention (Peters et 
al., 2009; 2011).   
 
In one study, data suggested that some patients may hold the belief that they should deal 
with their symptoms themselves, considering it inappropriate to discuss psychosocial 
problems (with the GP), with the idea of there being a stigma related to reporting 
psychosocial problems (Peters et al., 2009).   
 
Factors identified unhelpful or barriers to intervention success by health 
practitioners 
Across four studies, a finding with high confidence emerged around HPs’ perceptions 
about patient beliefs. HPs reported that they considered patient beliefs (such as not 
being able to take part in aspects of interventions that required physical activity) could 
be significant barriers to engagement with behavioural interventions (Dowrick et al., 
2008; Peters et al., 2011; Lewis et al., 2013).  In one study, HPs described, and some 
appeared to expect, patients to hold a belief in a physical cause for their symptoms and 
suggested this could be a barrier to engagement with the intervention, ‘Well it's their 
mindset isn't it? It's their belief that there is a physical cause.’ (GP, Dowrick et al., 
2008). 
 
HPs reported that their own emotions could be a source of difficulty in delivering PPS 
interventions in two studies (Peters et al., 2011; Lewis et al., 2013).  Nurse therapists 
found at times that they did not deal well with perceived failure, when patients felt the 
intervention was not suitable or working for them, ‘One common theme I think with has 
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come up is the difficult of accepting that you can’t get it right all the time.’ (Nurse 
Therapist Supervisor, Peters et al., 2011).  
 
In two separate studies nurse therapists and CBT therapists who had been trained to 
deliver PPS specific interventions felt that they were novices and lacked the experience 
to deliver the interventions (Lewis et al., 2013; Peters et al., 2011). CBT therapists 
experienced anxiety due to this lack of training and experience in PPS (Lewis et al., 2013), 
whereas nurse-therapists were not comfortable dealing with the mental health aspects as 
compared with the physical health aspects of the interventions they were delivering 
(Peters et al., 2011).  This also emerged as a barrier to service provision, with GPs 
acknowledging that the successful application of an intervention may be affected by 
variations in the communication skills of the practitioner delivering the intervention 
(Dowrick et al., 2008). 
 
Time constraints, and impositions about what data needed to be collected during a 
consultation presented barriers to HPs delivering interventions in three studies (Dowrick 
et al., 2008; Peters et al., 2011; Cowell et al., 2018a; Cowell et al., 2018b).  Concerns 
regarding time constraints were associated with each individual consultation (Dowrick 
et al., 2008) as well as the length of the course of therapy, with reservations expressed 
that too few sessions were available to deal with deep-seated issues (Peters et al., 2011).  
GPs were concerned about medico-legal issues, such as over-diagnosing and over-
treating patients in one study (Dowrick et al., 2008).  
 
Potential unwanted or adverse effects on patients 
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Lack of understanding of their situation from HPs was reported by patients in two 
studies (Peters et al., 2009; Morton et al., 2016), with low confidence in this finding. 
Sometimes this extended to patients feeling that they were being blamed by the GP 
(Morton et al., 2016).  ‘Well that's what I'm saying … how could I put it … I don't know, 
I felt as if Dr. D was maybe thinking I was getting a bit lazy or something like that, you 
know, which definitely I'm not that type of person, I'm not a lazy person, you know, I felt 
quite uncomfortable with that. He never actually said that, you know what I mean, but I 
just felt that within myself, you know.’ (Patient, Morton et al., 2016). 
 
Conflicts between HPs and patients were reported by patients in one study (Chew-
Graham et al., 2011; Peters et al., 2011). This occurred when patients felt the HPs were 
indicating that the intervention (in this case pragmatic rehabilitation for CFS/ME) was 
the only appropriate intervention, and the patients disagreed with this, ‘I think my main 
reason is the fundamental theory behind it [the treatment model offered] just disregards 
it as illness’.(Patient, Chew-Graham et al., 2011).  
 
In one study patients reported finding it difficult when the intervention came to an end, 
experiencing a feeling of loss when support was withdrawn (Peters et al., 2011; Chew-
Graham et al., 2011). HPs in two other studies reported similar concerns, with those in 
one study worrying patients might form a dependent relationship with the GP, and 
become reliant on them (Dowrick et al., 2008), and a concern about withdrawing 
support in the other, ’I just hope she doesn’t get a divorce...I am frightened in case I 





Table 9 Summary of the key findings – about here 
 
Discussion 
This review presents patient and health practitioner (HP) perspectives about the 
acceptability, relative benefits and potential harms of primary care- or community-based 
behavioural interventions for persistent physical symptoms (PPS).  Our findings offer 
insight into which aspects of the interventions described patients and HPs found helpful, 
what was unhelpful, and what were the potential barriers to patient participation or a 
successful intervention. These could all contribute towards an understanding of what 
might make a more successful intervention. Patients valued support, coherent 
explanations of their symptoms and good relationships with HPs, whilst HPs felt 
extending their own knowledge and developing a therapeutic relationship would 
facilitate a successful intervention. Patient barriers included problematic relationships 
with HPs and a lack of knowledge regarding the intervention and its remit at the time of 
referral. 
Across all the interventions, patients’ valued gaining support, being accepted and 
validated by the HP (and by other intervention participants in the case of group 
interventions), receiving empathy and being listened to. These findings are consistent 
with previous findings that have demonstrated the importance of the therapeutic 
relationship between patients and HPs in working with people with PPS (Smith et al., 
2003; Heijmans et al., 2011; Gask et al., 2011). This HP validation and support may 
however often be lacking, and poor communication between GPs and patients can cause 
barriers to effective treatment of PPS. Picariello et al’s (2015) survey of people with 
CFS reported that participants often felt a lack of empathy and understanding from HPs. 
Potential barriers include, unempathic HP communication styles and behaviours during 
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the consultation, patient health beliefs about treatment in the primary care setting, the 
extent of problem-exploration, HPs attitudes towards patients, a biomedical disease 
model approach, HPs knowledge of PPS, and level of confidence in treatment (Murray 
et al., 2016). Being less well informed about PPS may affect practitioner attitudes in a 
way which isn’t always helpful for patients. GPs can find such presentations frustrating 
and difficult if they don’t lead to very therapeutic consultations, resulting in a negative 
impact on the doctor-patient relationship (Wileman et al. 2002). Patients are more likely 
to feel that they are being taken seriously when the GP is aware of their personal 
circumstances and has an open and empathic approach (McLeod et al., 1997; Peters et 
al., 2002; Smith et al., 2006), treats the patient as an equal (McLeod et al., 1997; 
Morriss et al., 2007) and explores their symptoms in depth and acts upon them (Morriss 
et al., 2007; Ryan & Gevirtz, 2004). Effective explanations of symptoms have been 
shown to be empowering for some patients (Sowinska & Czachowski, 2018). A recent 
metanalysis of studies based on Leventhal’s common-sense model and outcomes in PPS 
showed patients who report a greater understanding of their condition report lower 
symptom severity, lower psychological distress and better quality of life (McAndrew et 
al., 2019).     
 
Clinical implications 
The impact of not feeling believed, or not having symptoms taken seriously may have a 
significant detrimental impact, leading to feelings of shame associated with a perceived 
invalidation of symptoms (Wearden et al., 2010). Validation has been shown to be critical 
for patients in a qualitative study comparing psychoeducation and CBT for CFS, 
regardless of the effectiveness of an intervention (Dennison et al., 2010). Therefore, the 
importance of a good therapeutic relationship and credible explanations of symptoms 
21 
 
should be key to any future intervention. Being able to provide flexible explanations that 
take into account individual differences between patients and taking account of patients’ 
own health beliefs may be important. In some cases HPs felt the training they had received 
was not enough, highlighting a need for more specific training, which was consistent with 
patients finding a lack of knowledge and skills in HPs a barrier. Specifically, CBT 
therapists wanted to extend their knowledge of PPS, whilst GPs and nurse-therapists 
wanted to improve their knowledge of psychological interventions, and thus increase their 
confidence in discussions with patients.  
 
Our findings as well as previous findings (Gerskowitch et al., 2015), show that if 
patients do not have the information required for an informed choice it is less likely that 
the intervention will be suitable for them, therefore it is important to provide accurate 
information, and to support HPs to provide this information prior to referral. Some 
patients reported finding it difficult when the intervention came to an end. It is 
important therefore to consider when developing future interventions that some patients 
may experience such effects, and how this should be addressed.  
 
As the review showed, there are a number of ways interventions can be delivered in 
primary care, and therefore the complexity of the primary care setting should also be 
considered and acknowledged in the development of new interventions. The settings 
covered here included GPs delivering interventions to their own patients, or coordinating 
care of another HP, and where the intervention might take place away from a GP practice 
but not in secondary care. Although, it is difficult to make specific recommendations 
about which type of primary care setting is optimal, there is a perceived importance to 
some involvement with primary care rather than being referred directly to secondary care, 
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Whilst the importance of the findings cannot be understated, some included studies 
were of moderate or low quality and the findings assessed as moderate or low 
confidence using the CERQual assessment (Lewin et al.,2015). Such limitations may 
result in a lack of rich data consistently across all studies, limiting the degree to which 
interpretations can be made for some of the findings (Booth et al., 2018). Variation 
across type of intervention, setting, the patient population, and health professionals 
being from very different professions with different levels of understanding of PPS, will 
also have had an impact on how data were collected and the type of data yielded in the 
primary studies. Furthermore, not all intervention studies have nested qualitative 
studies, for example in a report linked to this study (Leaviss et al., 2020) 59 studies 
were identified for the quantitative review, compared to only 9 studies in this qualitative 
review, this difference will also bias what we know about the interventions. In addition, 
the findings are reflective of a patient population attending primary care. This does not 
necessarily generalise to PPS patients in secondary care. All of these factors limit our 
ability to generalise the findings when assessing wider acceptability. 
 
Finally, it is important to note that qualitative analysis relies to some degree on the 
reviewer’s understanding and interpretation of the data, with the potential for a range of 
ways of interpreting this. To ensure that the qualitative synthesis was reliable as 
possible, two reviewers were involved in selecting and data extracting studies, and a 
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PPS are common in primary care, with GPs playing a major role in identifying and 
managing such patients. The quality of this care and the importance of it being 
acceptable to patients cannot be understated. Future research, in the form of 
Randomised Controlled Trials, to assess the feasibility, acceptability and effectiveness 
of behavioural interventions for PPS delivered in primary care is important. These 
interventions should emphasise the validation of patients’ symptoms and address the 
factors we have identified here as important, including patients gaining support, 
effective explanations of symptoms and good relationships with their HPs, with 
adequate information about any proposed intervention provided to patients at the time 
of referral. These interventions should be delivered by HPs that have been trained to 
deliver the intervention with specific knowledge of PPS and should have the skills to 
develop a therapeutic relationship. As it is currently unclear what and how GPs learn 
about PPS, studies on the impact of specific educational initiatives with different groups 
of HPs should be undertaken, together with process research on what distinguishes a 




Patients valued being supported and being provided with explanations for their 
symptoms. Training for health professionals was thought to be helpful and may address 
barriers that were underpinned by the relationship between the patients and HPs 
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delivering the intervention where this was not therapeutically effective. Interventions 
should not end suddenly, or without adequate follow-up or booster sessions. Multiple 
key enabling factors to inform the development of future interventions were identified, 
and patients should be provided with adequate information to make an informed 
decision when offered such interventions. These findings, together with the findings of 
the wider report which also included a quantitative evidence synthesis and economic 
modelling, has identified research recommendations for primary research in this 
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Persistent physical symptoms ‘PPS’ is a portfolio term covering a wide range of 
presentations in referring to persistent bodily complaints, including pain and discomfort. 
PPS are often associated with psychological distress and functional impairment 
(Dirkzwager & Verhaak, 2007). The term has also been applied to patients presenting 
with chronic fatigue syndrome, also termed myalgic encephalomyelitis (CFS/ME); 
irritable bowel syndrome (IBS); or fibromyalgia, which are usually referred to as 
functional somatic syndromes (FSS) (Wessely et al., 1999). The term PPS is used in this 
paper rather than medically unexplained symptoms (MUS). The term MUS is 
controversial, and debate regarding its use is on-going. For many patients with 
symptoms that are not, in the current state of medical knowledge, readily explicable by 
organic disease, a diagnostic label is important.  However, the label ‘medically 
unexplained symptoms’ can be regarded as offensive (Stone et al., 2002), and it has 
been suggested that the use of the term is a barrier to improved care (Creed et al.2010). 
Results of an online survey of healthy adults demonstrated that the most popular term to 
refer to persistent bodily complaints, including pain and discomfort, was PPS, and was 
more acceptable than the term MUS (Marks & Hunter (2015). A further study 
(Picariello et al., 2015) demonstrated that patients with CFS preferred the term PPS to 
describe their own condition, and also illnesses such as IBS and non-cardiac chest pain. 
Whilst we have used the term PPS in this paper, previous academic literature has 
generally used the term MUS, therefore it was necessary to use that term whilst 
conducting our literature searches, and we have kept references to MUS in this paper 
where appropriate in order to accurately report these previous findings.   
 
Main document (incl. figs and tables)
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Diagnostic criteria for PPS are varied and patients visiting their GP frequently with 
unexplained symptoms are not necessarily offered a formal diagnosis. In the UK, Taylor 
et al. (2012) report a prevalence rate of 18% in consecutive attenders to UK GP 
practices. Worldwide prevalence rates of primary care patients presenting with PPS 
have been reported as between 25% and 50% (Edwards et al., 2010). It has been 
estimated that 50-75% of patients with PPS will improve, whilst between 10% and 30% 
will see their condition deteriorate (Olde Hartman et al., 2009). However, a recent study 
has reported that only 11% of UK primary care patients had recovered at 6 months and 
55% were still having persistent symptoms (Lamahewa et al., 2019). 
 
Generally, interventions offered for PPS, across a variety of health settings, are based 
around pharmacological, psychological, or physical therapeutic models. 
Pharmacological interventions have been shown to produce some improvement in 
patients in terms of symptom severity and functioning (Kroenke, 2007, Hoedeman et 
al., 2010, Ford et al., 2009), although with significant heterogeneity of efficacy between 
different FSS.  
 
The evidence for interventions that aim to promote cognitive, emotional and/or 
behavioural change is mixed, with cognitive behaviour therapy (CBT) appearing to 
have the most consistent evidence. CBT for PPS is based on the broader model which 
suggests an acute event such as injury or infection precipitates the symptoms which are 
then perpetuated though an interaction of cognitive, behavioural, emotional and 
physiological factors. CBT and behavioural based therapies aim to alter one or more of 
these factors to reduce the severity and/or impact of the symptoms. For instance, worry 
about symptoms can heighten autonomic nervous responses and sensitisation to 
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symptoms.  Prolonged periods of inactivity due to the fear that activity is harmful, may 
impact sleep and muscle integrity and exacerbate symptoms such as pain and fatigue. 
For fibromyalgia, CBT has been shown to improve physical symptoms and functioning 
(Arnold et al., 2012), as have exercise therapies (Marcus, 2009, Busch et al., 2007). A 
recent network meta-analysis of the psychological interventions for IBS concluded CBT 
and gut-directed hypnotherapy had the largest evidence base and were the most 
effective at reducing the severity of IBS long term (Black et al., 2020). However, the 
authors noted that there was significant heterogeneity between studies and issues 
regarding trial design, including lack of blinding, which may mean treatment effects 
were overestimated. A 24 month follow up of the largest CBT trial for IBS to date 
showed that effects were largely at sustained at 24 month follow up compared to usual 
care (Everitt et al., 2019). A Cochrane review of CBT for CFS (Price et al., 2018), 
concluded CBT was more effective at reducing fatigue at the end of treatment than 
usual care and wait list control as well as other therapies such as relational counselling.  
The data for longer term follow-up was more mixed.  The review also concluded that 
there was a paucity of studies on the acceptability and possible side effects of CBT.    
 
General practitioners (GPs) play a major role in identifying and managing patients with 
PPS. Most patients with PPS will be seen initially in primary care, often for many 
consultations, prior to referral to secondary care, or less often specialist services. 
However, the majority of the research in this patient group has been conducted in 
secondary care with less evidence specific to the primary care setting. The relationship 
between patients and service providers has been reported as key to the success of 
primary care interventions in PPS in a number of studies (Smith et al 2003, Heijmans et 
al., 2011; Gask et al., 2011). Poor communication between GPs and patients during 
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medical consultations, and lack of emotional and practical support are suggested 
barriers to effective recognition and treatment of PPS (Murray et al., 2016). These 
barriers may limit opportunities to explore contributing factors and appropriate 
interventions. Creating a safe, therapeutic environment, and offering effective 
reassurance, are important enabling factors (Heijmans et al., 2011), thus highlighting the 
need for acceptability of interventions for both patients and health care practitioners.  
 
This is the first qualitative systematic review, to our knowledge, to specifically explore 
the acceptability of behavioural interventions for diverse PPS populations based in 
primary care, including patients meeting the criteria for MUS, Medically Unexplained 
Physical Symptoms (MUPS), and somatoform disorders, and including populations 
with specific FSS, e.g. IBS, CFS, fibromyalgia. Previous qualitative systematic reviews 
have only examined patients’ experiences more generally, in terms of how patients, 
family and the medical community interpret the illness, not relating to experiences of 
undertaking behavioural interventions (Anderson et al., 2012). The objectives of this 
study were; to synthesise evidence relating to the barriers and facilitators of the 
acceptability of primary care or community-based behavioural interventions for 
Persistent Physical Symptoms, in the UK, from the perspective of both patients and 
service providers, by undertaking a comprehensive systematic review of the available 
qualitative research literature, using rigorous methods for review and evidence 
synthesis. 
Methods 




The search methods sought to identify evidence in the form of qualitative research, 
qualitative data reported in mixed methods research, and qualitative data embedded in 
trial reports or process evaluations. A systematic search strategy was developed by a 
library information specialist (ASu) to identify this evidence relating to a primary care 
or community-based population; population terms were combined with terms that 
define the setting. Published methodological search filters to limit results to qualitative 
studies were used where available (ISSG, 2019), and was combined with a geographic 
filter to identify UK studies only.  No other search limits were applied. Initial search 
results therefore covered the period from 1980 to July 2016, updated in February 2019, 
in 7 electronic databases including MEDLINE, Embase, CINAHL, PsycINFO, Science 
Citation Index, and Social Sciences Citation Index . Citation searching and reference list 
searching, were also undertaken to identify any further citations that may not have 
appeared in electronic databases. (see supporting materials for further information). 
Screening and eligibility 
Titles and abstracts of all citations retrieved through the searches were scrutinised by 
one systematic reviewer (ASc) according to the inclusion and exclusion criteria (Table 
1.).  Agreement on inclusion at title/abstract sift was checked by a second systematic 
reviewer (AB) for 20% of the total electronic search results. Agreement was calculated 
using the Kappa statistic. Given a Kappa statistic of 0.77, (i.e. above recognised 
acceptable levels (0.7)) double sifting was not deemed necessary. All full texts were 
considered for inclusion by two reviewers (ASc & AB). Disagreements on study 
inclusion were resolved with reference to a third reviewer (JL).   
Table 1. Inclusion and exclusion criteria. – about here 
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Quality assessment strategy 
Inclusion criteria for study design were broad, with any study presenting qualitative 
evidence being eligible. Therefore, a study quality checklist for qualitative studies was 
developed prior to study screening (using an adapted form of the CASP checklist for 
qualitative research), to allow flexibility in accommodating findings from studies with 
research designs that were not primarily qualitative in nature (see table 2).  No studies 
were excluded on the basis of quality (Carroll & Booth, 2015).  
 
Table 2.  The Quality Assessment Questions applied to included studies – about 
here 
Quality constituted one aspect of the assessment of the confidence of findings from the 
included studies, using CERQual as described below in the methods of synthesis 
section. 
Data extraction strategy 
Data extraction was undertaken by one reviewer (ASc) using a data extraction tool 
tailored for the purpose of this review. All data extractions were checked by a second 
reviewer (AB), with discrepancies discussed by both reviewers. Given the anticipated 
paucity of relevant evidence, an inclusive approach to data extraction was employed in 
which all qualitative data identified in the primary studies and relevant to the review 
question was extracted (Noyes and Lewin, 2011). The framework for extraction allowed 
data from the primary studies to be extracted verbatim into general categories relating to 
the review question, directly from the papers, as illustrated in Table 3 below. This 
allowed familiarisation with the data and was akin to assigning preliminary codes to the 
data, which described the content. 
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Table 3. Framework for data extraction – about here 
Data Synthesis Strategy 
Thematic synthesis was used to aggregate the data (Thomas & Harden, 2008). Themes 
were developed within the data extraction elements (table 3). Specifically, one reviewer 
(ASc) went through the data assigning preliminary codes line by line according to its 
meaning and content. These codes were then organised and grouped together to become 
sub themes, which were largely descriptive, and which were later grouped into over-
arching themes, which were more ‘analytical’. Line by line coding allowed the 
translation of concepts from one study to another; as each study was coded new data 
were added to existing codes, and new codes were developed as necessary. These sub 
themes remained very close to the original findings, whilst the over-arching themes 
went beyond the findings of the original study to suggest new understandings, based on 
the judgement and insights of the reviewers.  
The Confidence in the Evidence from Reviews of Qualitative research (GRADE-
CERQual) (Lewin et al., 2015) approach was used to summarise confidence in findings 
from included studies. CERQual assesses confidence in synthesised review findings 
based on the four key components of methodological limitations, adequacy, coherence 
and relevance. Confidence in each review finding was judged as high, moderate, low, or 
very low, as defined according to the CERQual approach (see supporting information 
for further definition).   
Results 
From the 2119 citations identified from the searches, 58 remained after title and abstract 
sift, and were considered at full paper sift. Twelve full papers reporting evidence from 
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nine studies were included in the review.  Figure 1 shows the PRISMA flow chart of 
studies included in the qualitative review. All included full papers were published 
between 2007 and 2018. 
 
Figure 1: PRISMA Flow Diagram– about here 
Study respondents 
Eight studies provided evidence about patients’ attitudes and four studies provided 
evidence about HP attitudes to the intervention. Overall, the studies contained 
qualitative data from 130 patients, and from 48 HPs. HP data were derived specifically 
from 24 general practitioners (GPs), 10 physiotherapists, 8 CBT therapists, 3 Nurse 
therapists, and 3 nurse therapist supervisors (see Table 4). 
 
Table 4 Summary of the included studies and their sample and study 
characteristics – about here 
  
Respondent characteristics 
Six studies focused on interventions for MUS/MUPS, one for CFS/ME, one for Non-
specific chronic low back pain and one defined as for somatisation, where all patients 
included in the study were described as presenting with physical symptoms that were 
medically unexplained. Of the 130 patients taking part in the included studies most 
patient participants met the criteria for MUS or MUPS (n=84) with the remaining 46 
patients diagnosed with CFS/ME. Reporting of participant characteristics was limited 
and incomplete in several studies.  Details where reported are shown in Tables 5 and 6 
below.   
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Table 5 Summary of patient characteristics – about here 
 
Table 6 Summary of health practitioner characteristics – about here 
Intervention description and facilitators 
Three interventions were delivered by GPs (Peters et al., 2009; Dowrick et al., 2008; 
Burton et al., 2012; Morton et al., 2016), one by nurse-therapists in a single study 
(Chew Graham et al., 2011; Peters et al., 2011), and one by physiotherapists in a single 
study (Cowell et al., 2018a; Cowell et al., 2018b). Trained CBT therapists delivered one 
intervention investigated in two studies (Gerskowitch et al., 2015; Lewis et al., 2013). A 
psychological well-being practitioner (PWP) delivered a low intensity CBT intervention 
and a trained facilitator delivered a mindfulness-based stress reduction (MBSR) 
intervention in one of these studies (Gerskowitch et al., 2015). Group counselling 
(humanistic) was facilitated by a ‘group counsellor’ (Graham, 2007), and the BodyMind 
Approach intervention was delivered by clinical psychologists together with facilitators 
who were psychotherapists or art therapists (Payne et al., 2015).  Most interventions 
were delivered individually to patients; however, three interventions were delivered in a 
group setting, i.e. MBSR, humanistic counselling, and the BodyMind approach 
(Gerskowitch et al., 2015; Graham, 2007 & Payne et al., 2015). (see table 7)   
 
Table 7 Description of the interventions delivered in the included studies – about 
here 
 
Quality of the included studies 
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Results of the quality assessment for each study are presented in Table 8. The quality 
levels to be applied to the evidence, high, moderate or low were chosen to be 
conservative. The reviewing team made a judgement that a study must meet all criteria 
to be regarded as high quality. If any criterion was not fulfilled the study was regarded 
as moderate quality. However if more than one criterion had not been achieved it was 
concluded that it was not possible to assess the study as high or moderate quality. 
 
Table 8 Quality assessment results for the included studies. – about here 
 
Certainty of the review findings – CERQual assessment 
The CERQual approach utilised the methodological quality of each study contributing 
to the review finding.  Relevance was assessed by considering the format of the 
intervention, (whether individual or group based), and the facilitator, (whether a GP, 
nurse therapist, or psychological therapist). Given that the inclusion criteria specified a 
primary care- or community-based setting, this criterion was not considered in the 
analysis of relevance. Coherence was assessed by considering if all the data contributing 
to a finding supported that finding and the presence of ambiguities or plausible 
alternative explanations.  Finally, adequacy was assessed by considering the richness 
and quantity of data supporting each review finding.  The synthesis of evidence from 
patients yielded 22 review findings.  Only one finding was assessed as high confidence, 
six findings were assessed as moderate confidence, 13 were assessed as low confidence 
and two as very low confidence.  The evidence from HPs yielded 16 findings overall.  
Four findings were assessed as high confidence, eight as moderate confidence, and four 
as low confidence. (The results of the CERQual assessment are set out alongside each 




Synthesis of patient and health practitioner evidence 
Data were synthesised across all intervention types and organised according to the 
questions outlined in the data extraction framework (table 2). Each theme and sub-
theme, together with evidence from the primary studies and an estimate of the strength 
of the evidence are presented within the following narrative synthesis, and also in Table 
S1 and Table S2 (supporting materials).  
 
Factors identified as important in interventions for PPS from the perspective of 
patients who had received the interventions 
Support 
Feeling supported was defined by patients as being accepted and validated by the HPs, 
receiving empathy, and being listened to.  This need for support was identified across 
diverse intervention types with high confidence in this finding (Gerskowitch et al., 2015; 
Chew-Graham et al., 2011; Graham, 2007; Morton et al., 2016; Peters et al., 2009; Peters 
et al., 2011; Payne et al.; 2015). Such support was described as the most positive part of 
the pragmatic rehabilitation intervention in one study, with ‘being believed and feeling 
understood by the therapist’ identified as a key part of the intervention (Chew-Graham et 
al., 2011).  Patients across various intervention types reported being validated by the HP 
as important (Chew-Graham et al., 2011; Gerskowitch et al., 2015).  This feeling was 
sometimes due to the knowledge the HP had of the patient’s symptoms giving them a 
sense of having someone ‘on their side’ (Gerskowitch et al., 2015; Morton et al., 2016; 
Peters et al., 2009).  In some instances, it appeared that no one else in their lives was able 
to provide such support, ‘It was just an understanding from her that I didn’t, haven’t had 
from anybody else’ (Patient, Chew-Graham et al., 2011). One patient reporting that the 
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empathetic nature of the nurse delivering the supportive listening intervention was their 
most valued attribute (Peters et al., 2011). 
 
The feeling of being understood also came from fellow participants with similar 
symptoms within group interventions (Gerskowitch et al., 2015; Graham et al., 2007; 
Payne et al., 2015).  These factors were reported as key to patient engagement and 
contributed to whether the interventions were reported as acceptable to the participants 
(Chew-Graham et al., 2011).   
 
Explanation 
Patients valued explanations of their symptoms which they had been provided with as 
part of the interventions. They reported that this led to their acceptance and understanding 
of the treatment model, both for a CBT for MUPS study (Gerskowitch et al., 2015) and a 
pragmatic rehabilitation for CFS study (Chew-Graham et al., 2011), with moderate 
confidence assessed in this finding.  They also felt that the pragmatic rehabilitation 
intervention helped them to come to terms with and accept a diagnosis (of CFS) and that 
having an explanation and understanding of their symptoms was key to this. ‘She 
explained all about CFS and the physiology of it really, which was the first time really 
that I understood why my energy was so low, so that made a lot of sense.’ (Patient, Chew-
Graham et al., 2011). Gaining new knowledge about their symptoms was reported to be 
reassuring to patients enabling them to make an initial judgement about whether the 
intervention might be appropriate for them (Chew-Graham et al., 2011).  Patients reported 
that they consulted their GP in order to seek an explanation for their symptoms (Peters et 
al., 2009), and took part in interventions to see someone who had specialist knowledge 




Important factors for the delivery and success of interventions from the 
perspective of patients 
With interventions where behavioural self-management techniques were taught, some 
patients reported they had benefited from these. This was evidenced across four of the 
studies which included the following interventions; CBT for MUPS, Mindfulness, 
group counselling, GP with a special interest ‘symptoms’ clinic and the BodyMind 
approach intervention. Participants commented on their improved confidence 
(Gerskowitch et al., 2015; Graham, 2007; Morton et al., 2016; Payne et al., 2015) and 
improved communication with significant others, ‘I have spoken to friends about my 
feelings and hold fewer grudges.’ (Patient, Graham, 2007). Specific to group 
interventions patients found sharing their experiences with other patients, (Gerskowitch 
et al., 2015) and learning skills from other patients (Gerskowitch et al., 2015; Graham, 
2007) valuable as part of the intervention. 
 
Patients reported needing reassurance and a good relationship with the person delivering 
the intervention (Peters et al., 2009). Patients involved in a reattribution intervention 
liked having a longstanding relationship with the GP, and this gave giving them a 
feeling that the HP would know what type of treatment, if any, would be suitable for 
them, ‘He knows I like to keep myself to myself, knows I believe in self-help...knows I’m 
somebody that likes to work it out for myself’. (Patient, Peters et al., 2009). Others 
appreciated the understanding and reassurance they received from the HP and just 




Important factors for the delivery and success of interventions from the 
perspective of health practitioners 
Across four studies, and with high confidence in this finding, HPs reported positive 
factors around extending their own knowledge and skill. They reported training and 
supervision in applying behavioural interventions as helpful, and developed their 
knowledge and skills in the area of PPS (Peters et al., 2011; Dowrick et al., 2008; Cowell 
et al., 2018a; Cowell et al., 2018b). Training helped them to learn about the boundaries 
of their own role (Peters et al., 2011), and to be flexible when delivering interventions 
(Peters et al., 2011; Lewis et al., 2013). In one study, some GPs reported that reattribution 
training increased their confidence in discussing PPS, and to reflect on management 
decisions, ‘I'd like to think that I do go a little bit more into other agendas, other issues 
that might be fuelling the symptoms that they've got and try and approach those other 
problems rather than just focusing on a prescription for something for pain’ (GP, 
Dowrick et al., 2008). 
 
In three studies, contributing to a finding of high confidence, (Lewis et al., 2013; Peters 
et al., 2011; Cowell, 2018a; Cowell, 2018b) HPs reported that it can be rewarding when 
it is evident that patients have gained benefit from the intervention. ’And it was like 
watering a flower it was really lovely for me personally... it was lovely watching her just 
blossom, you know what I mean, because she finally took on board the physical stuff and 
the sleep.’ (Nurse, Peters et al., 2011) 
 
The primary care or community setting was reported to be a helpful factor by the HPs in 
two studies.  In one study the reason for this was that the primary care setting allowed for 
a more tailored approach, or that the setting, such as being in patients homes, was useful 
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when trying to develop a therapeutic relationship (Peters et al., 2011).  In another case 
this contrasted with the perceived potential failing of the secondary care setting (Dowrick 
et al., 2008). ‘You see these people getting referred to the hospital with back pain and the 
next thing you know some bright spark is going to operate on them and you think 
‘What!’….Maybe we’re here in a way as a gateway to try and prevent harm as well as 
anything else.’ (GP; Dowrick et al., 2008). This appears to indicate that primary care 
practitioners see part of their role as protecting their patient from entering secondary care 
where they believed this was unnecessary.   
 
Factors identified as barriers to intervention success by patients 
Patients reported a feeling of scepticism toward HPs, with data contributing to this finding 
across four studies with moderate confidence. This included the concern that mentioning 
psychosocial problems would divert GP attention away from other physical problems 
associated with their symptoms (Peters et al., 2009), and in one study, patients had the 
feeling that the aim of the GP was to assert their problems were psychological (Burton, 
et al. 2012). Patients also reported being concerned that they would only be provided with 
simplistic explanations for their symptoms, as in a study of CBT for MUPS delivered by 
CBT therapists (Gerskowitch et al., 2015). 
  
Patients reported that the lack of information given to them by those that referred them to 
the study meant that they did not know the remit of the intervention, and that the referring 
GP also often did not know what the intervention entailed.  Patients were therefore 
surprised by the content of the intervention and found it difficult to see why they had been 
referred to a psychological therapy-based intervention when they perceived their 
problems as physical (Gerskowitch et al., 2015). There was also a feeling from patients 
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in two studies, that some HPs, GPs and nurse-therapists, were unskilled or lacked the 
knowledge to deal with their symptoms or provide an appropriate intervention (Peters et 
al., 2009; 2011).   
 
In one study, data suggested that some patients may hold the belief that they should deal 
with their symptoms themselves, considering it inappropriate to discuss psychosocial 
problems (with the GP), with the idea of there being a stigma related to reporting 
psychosocial problems (Peters et al., 2009).   
 
Factors identified unhelpful or barriers to intervention success by health 
practitioners 
Across four studies, a finding with high confidence emerged around HPs’ perceptions 
about patient beliefs. HPs reported that they considered patient beliefs (such as not 
being able to take part in aspects of interventions that required physical activity) could 
be significant barriers to engagement with behavioural interventions (Dowrick et al., 
2008; Peters et al., 2011; Lewis et al., 2013).  In one study, HPs described, and some 
appeared to expect, patients to hold a belief in a physical cause for their symptoms and 
suggested this could be a barrier to engagement with the intervention, ‘Well it's their 
mindset isn't it? It's their belief that there is a physical cause.’ (GP, Dowrick et al., 
2008). 
 
HPs reported that their own emotions could be a source of difficulty in delivering PPS 
interventions in two studies (Peters et al., 2011; Lewis et al., 2013).  Nurse therapists 
found at times that they did not deal well with perceived failure, when patients felt the 
intervention was not suitable or working for them, ‘One common theme I think with has 
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come up is the difficult of accepting that you can’t get it right all the time.’ (Nurse 
Therapist Supervisor, Peters et al., 2011).  
 
In two separate studies nurse therapists and CBT therapists who had been trained to 
deliver PPS specific interventions felt that they were novices and lacked the experience 
to deliver the interventions (Lewis et al., 2013; Peters et al., 2011). CBT therapists 
experienced anxiety due to this lack of training and experience in PPS (Lewis et al., 2013), 
whereas nurse-therapists were not comfortable dealing with the mental health aspects as 
compared with the physical health aspects of the interventions they were delivering 
(Peters et al., 2011).  This also emerged as a barrier to service provision, with GPs 
acknowledging that the successful application of an intervention may be affected by 
variations in the communication skills of the practitioner delivering the intervention 
(Dowrick et al., 2008). 
 
Time constraints, and impositions about what data needed to be collected during a 
consultation presented barriers to HPs delivering interventions in three studies (Dowrick 
et al., 2008; Peters et al., 2011; Cowell et al., 2018a; Cowell et al., 2018b).  Concerns 
regarding time constraints were associated with each individual consultation (Dowrick 
et al., 2008) as well as the length of the course of therapy, with reservations expressed 
that too few sessions were available to deal with deep-seated issues (Peters et al., 2011).  
GPs were concerned about medico-legal issues, such as over-diagnosing and over-
treating patients in one study (Dowrick et al., 2008).  
 
Potential unwanted or adverse effects on patients 
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Lack of understanding of their situation from HPs was reported by patients in two 
studies (Peters et al., 2009; Morton et al., 2016), with low confidence in this finding. 
Sometimes this extended to patients feeling that they were being blamed by the GP 
(Morton et al., 2016).  ‘Well that's what I'm saying … how could I put it … I don't know, 
I felt as if Dr. D was maybe thinking I was getting a bit lazy or something like that, you 
know, which definitely I'm not that type of person, I'm not a lazy person, you know, I felt 
quite uncomfortable with that. He never actually said that, you know what I mean, but I 
just felt that within myself, you know.’ (Patient, Morton et al., 2016). 
 
Conflicts between HPs and patients were reported by patients in one study (Chew-
Graham et al., 2011; Peters et al., 2011). This occurred when patients felt the HPs were 
indicating that the intervention (in this case pragmatic rehabilitation for CFS/ME) was 
the only appropriate intervention, and the patients disagreed with this, ‘I think my main 
reason is the fundamental theory behind it [the treatment model offered] just disregards 
it as illness’.(Patient, Chew-Graham et al., 2011).  
 
In one study patients reported finding it difficult when the intervention came to an end, 
experiencing a feeling of loss when support was withdrawn (Peters et al., 2011; Chew-
Graham et al., 2011). HPs in two other studies reported similar concerns, with those in 
one study worrying patients might form a dependent relationship with the GP, and 
become reliant on them (Dowrick et al., 2008), and a concern about withdrawing 
support in the other, ’I just hope she doesn’t get a divorce...I am frightened in case I 





Table 9 Summary of the key findings – about here 
 
Discussion 
This review presents patient and health practitioner (HP) perspectives about the 
acceptability, relative benefits and potential harms of primary care- or community-based 
behavioural interventions for persistent physical symptoms (PPS).  Our findings offer 
insight into which aspects of the interventions described patients and HPs found helpful, 
what was unhelpful, and what were the potential barriers to patient participation or a 
successful intervention. These could all contribute towards an understanding of what 
might make a more successful intervention. Patients valued support, coherent 
explanations of their symptoms and good relationships with HPs, whilst HPs felt 
extending their own knowledge and developing a therapeutic relationship would 
facilitate a successful intervention. Patient barriers included problematic relationships 
with HPs and a lack of knowledge regarding the intervention and its remit at the time of 
referral. 
Across all the interventions, patients’ valued gaining support, being accepted and 
validated by the HP (and by other intervention participants in the case of group 
interventions), receiving empathy and being listened to. These findings are consistent 
with previous findings that have demonstrated the importance of the therapeutic 
relationship between patients and HPs in working with people with PPS (Smith et al., 
2003; Heijmans et al., 2011; Gask et al., 2011). This HP validation and support may 
however often be lacking, and poor communication between GPs and patients can cause 
barriers to effective treatment of PPS. Picariello et al’s (2015) survey of people with 
CFS reported that participants often felt a lack of empathy and understanding from HPs. 
Potential barriers include, unempathic HP communication styles and behaviours during 
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the consultation, patient health beliefs about treatment in the primary care setting, the 
extent of problem-exploration, HPs attitudes towards patients, a biomedical disease 
model approach, HPs knowledge of PPS, and level of confidence in treatment (Murray 
et al., 2016). Being less well informed about PPS may affect practitioner attitudes in a 
way which isn’t always helpful for patients. GPs can find such presentations frustrating 
and difficult if they don’t lead to very therapeutic consultations, resulting in a negative 
impact on the doctor-patient relationship (Wileman et al. 2002). Patients are more likely 
to feel that they are being taken seriously when the GP is aware of their personal 
circumstances and has an open and empathic approach (McLeod et al., 1997; Peters et 
al., 2002; Smith et al., 2006), treats the patient as an equal (McLeod et al., 1997; 
Morriss et al., 2007) and explores their symptoms in depth and acts upon them (Morriss 
et al., 2007; Ryan & Gevirtz, 2004). Effective explanations of symptoms have been 
shown to be empowering for some patients (Sowinska & Czachowski, 2018). A recent 
metanalysis of studies based on Leventhal’s common-sense model and outcomes in PPS 
showed patients who report a greater understanding of their condition report lower 
symptom severity, lower psychological distress and better quality of life (McAndrew et 
al., 2019).     
 
Clinical implications 
The impact of not feeling believed, or not having symptoms taken seriously may have a 
significant detrimental impact, leading to feelings of shame associated with a perceived 
invalidation of symptoms (Wearden et al., 2010). Validation has been shown to be critical 
for patients in a qualitative study comparing psychoeducation and CBT for CFS, 
regardless of the effectiveness of an intervention (Dennison et al., 2010). Therefore, the 
importance of a good therapeutic relationship and credible explanations of symptoms 
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should be key to any future intervention. Being able to provide flexible explanations that 
take into account individual differences between patients and taking account of patients’ 
own health beliefs may be important. In some cases HPs felt the training they had received 
was not enough, highlighting a need for more specific training, which was consistent with 
patients finding a lack of knowledge and skills in HPs a barrier. Specifically, CBT 
therapists wanted to extend their knowledge of PPS, whilst GPs and nurse-therapists 
wanted to improve their knowledge of psychological interventions, and thus increase their 
confidence in discussions with patients.  
 
Our findings as well as previous findings (Gerskowitch et al., 2015), show that if 
patients do not have the information required for an informed choice it is less likely that 
the intervention will be suitable for them, therefore it is important to provide accurate 
information, and to support HPs to provide this information prior to referral. Some 
patients reported finding it difficult when the intervention came to an end. It is 
important therefore to consider when developing future interventions that some patients 
may experience such effects, and how this should be addressed.  
 
As the review showed, there are a number of ways interventions can be delivered in 
primary care, and therefore the complexity of the primary care setting should also be 
considered and acknowledged in the development of new interventions. The settings 
covered here included GPs delivering interventions to their own patients, or coordinating 
care of another HP, and where the intervention might take place away from a GP practice 
but not in secondary care. Although, it is difficult to make specific recommendations 
about which type of primary care setting is optimal, there is a perceived importance to 
some involvement with primary care rather than being referred directly to secondary care, 
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Whilst the importance of the findings cannot be understated, some included studies 
were of moderate or low quality and the findings assessed as moderate or low 
confidence using the CERQual assessment (Lewin et al.,2015). Such limitations may 
result in a lack of rich data consistently across all studies, limiting the degree to which 
interpretations can be made for some of the findings (Booth et al., 2018). Variation 
across type of intervention, setting, the patient population, and health professionals 
being from very different professions with different levels of understanding of PPS, will 
also have had an impact on how data were collected and the type of data yielded in the 
primary studies. Furthermore, not all intervention studies have nested qualitative 
studies, for example in a report linked to this study (Leaviss et al., 2020) 59 studies 
were identified for the quantitative review, compared to only 9 studies in this qualitative 
review, this difference will also bias what we know about the interventions. In addition, 
the findings are reflective of a patient population attending primary care. This does not 
necessarily generalise to PPS patients in secondary care. All of these factors limit our 
ability to generalise the findings when assessing wider acceptability. 
 
Finally, it is important to note that qualitative analysis relies to some degree on the 
reviewer’s understanding and interpretation of the data, with the potential for a range of 
ways of interpreting this. To ensure that the qualitative synthesis was reliable as 
possible, two reviewers were involved in selecting and data extracting studies, and a 
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PPS are common in primary care, with GPs playing a major role in identifying and 
managing such patients. The quality of this care and the importance of it being 
acceptable to patients cannot be understated. Future research, in the form of 
Randomised Controlled Trials, to assess the feasibility, acceptability and effectiveness 
of behavioural interventions for PPS delivered in primary care is important. These 
interventions should emphasise the validation of patients’ symptoms and address the 
factors we have identified here as important, including patients gaining support, 
effective explanations of symptoms and good relationships with their HPs, with 
adequate information about any proposed intervention provided to patients at the time 
of referral. These interventions should be delivered by HPs that have been trained to 
deliver the intervention with specific knowledge of PPS and should have the skills to 
develop a therapeutic relationship. As it is currently unclear what and how GPs learn 
about PPS, studies on the impact of specific educational initiatives with different groups 
of HPs should be undertaken, together with process research on what distinguishes a 




Patients valued being supported and being provided with explanations for their 
symptoms. Training for health professionals was thought to be helpful and may address 
barriers that were underpinned by the relationship between the patients and HPs 
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delivering the intervention where this was not therapeutically effective. Interventions 
should not end suddenly, or without adequate follow-up or booster sessions. Multiple 
key enabling factors to inform the development of future interventions were identified, 
and patients should be provided with adequate information to make an informed 
decision when offered such interventions. These findings, together with the findings of 
the wider report which also included a quantitative evidence synthesis and economic 
modelling, has identified research recommendations for primary research in this 
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Figure 1: PRISMA Flow Diagram 
Records identified through 
database searching 































Additional records identified 
through other sources. 
Citation searching (5) 
Records after duplicates removed 
(2119) 
Records screened by 
title and abstract 
(2119) 
Records excluded at title 
and abstract sift 
(2061) 
Full-text articles 
assessed for eligibility 
(58 citations; 55 studies) 
Full-text articles 
excluded, with reasons 
(46 citations;46 studies) 
Does not include qualitative data = 
14 
Population did not fit the inclusion 
criteria = 19  
Does not include data about a 
specific intervention = 5 
Non-UK study = 3 
Not primary care = 2 
Mixed population = 1 
Opinion piece = 1 
Studies included in 





Table 1. Inclusion and exclusion criteria. 
  Included Excluded 
P – Population Patients meeting the criteria for PPS, 
MUS, MUPS, and somatoform 
disorders.  Populations with FSS were 
included, e.g. IBS, CFS, fibromyalgia.  
Health care providers who had 
delivered behavioural interventions 
designed for these patients were also 
included. 
Subacute patients.  Patients with 
intermittent pain (where current episode 
was less than 3 months – or this 
information was not available from the 
paper / or they cannot be disentangled 
from the rest of the sample.) 
I – Intervention Behavioural interventions delivered in a 
primary care or community-based 
setting, in the UK. (only UK studies 
were eligible for inclusion as this study 
aimed to synthesis evidence relating 
specifically to the UK primary care 
setting) 
Studies of management of PPS where 
evidence relating to a treatment of interest 
was not separately identifiable. 
C - Comparator N/A N/A 
O – Outcomes Qualitative data N/A 
S – 
Study design 
Qualitative research, mixed methods 
research, qualitative data embedded in 
trial reports or process evaluations 















Table 2.  The Quality Assessment Questions applied to included studies 
Question 
1 Is the study qualitative research or does it provide qualitative data 
2 Is the study context and aims clearly described? 
3 Is there evidence of research reflexivity? 
4 Are the sampling methods clearly described and appropriate for the research question? 
5 Are the methods of data collection clearly described and appropriate to the research question?  
6 Is the method of analysis clearly described and appropriate to the research question? 















Table 3. Framework for data extraction 
Data from 
patients 
Positive factors relating to behavioural interventions as reported by patients 
/ What did you gain from being referred to a behavioural intervention. 
Factors reported as important, wanted or expected in behavioural 
interventions 
What patients didn’t like about (being referred to) behavioural interventions 
Barriers – why patients didn’t want behavioural interventions / or couldn’t 
engage with them 




Positive factors relating to behavioural interventions as reported by health 
professionals / What did you gain from being trained to and/or delivering a 
behavioural intervention. 
Factors reported as important, wanted or expected for training in and 
delivery of behavioural interventions 
What did not help or was detrimental to the patients or delivery of the 
intervention. 
Barriers – from the perspective of health professionals as to why patients 
didn’t want behavioural interventions / or couldn’t engage with them, or 
barriers to delivery of the intervention 











Table 4 Summary of the included studies and their sample and study characteristics 
Author (date) Sample (contributing 
qualitative data) 
Population being treated 
as described in the study 
Data collection Intervention 
Burton et al. (2012) 11 Patients MUS Interview GP with special interest ‘symptoms’ 
clinic. 
Chew-Graham et al. 
(2011) 
Peters et al. (2011) 
3 nurse therapists, 3 
supervisors (psychiatry, 
clinical psychology, 
counselling), 46 patients.  
CFS/ME 
 
Semi-structured interviews Pragmatic rehabilitation and supportive 
listening. 
Cowell et al. (2018a; 
2018b) 
10 Physiotherapists Non-specific chronic low 
back pain 
Semi-Structured Interview Cognitive Functional Therapy 
Dowrick et al. (2008) 
Peters et al. (2009) (report 
different data from the 
study above) 
24 General practitioners MUS Semi-structured interviews 
 
Reattribution (by trained GPs) 
 23 Patients 




Graham (2007) 6 Patients MUS Self-reports – a series of open 
questions put to each patient in 
writing. 
Group counselling (humanistic) 
Lewis et al. (2013) 8 CBT therapists. MUS Semi-structured interviews Individual CBT 
Morton et al. (2016) 17 Patients MUS Semi-structured interviews GP with special interest ‘symptoms’ 
clinic. 
Payne et al. (2015) 16 Patients MUS Case studies; qualitative data from a 
survey 





Table 5 Summary of patient characteristics 






described in the 
study 
Gender Age 
Burton et al. (2012) 11 Patients MUS NR  NR  
Chew-Graham et 
al. (2011) 
Peters et al. (2011) 
46 patients. CFS/ME 
 
33 female; 13 
male 
Patients = Mean age 46.11 
years (range 20-73) 
Gerskowitch et al. 
(2015) 
11 Patients MUPS 8 female; 3 male Median age 50 years (range 
19-60). 
Graham (2007) 6 Patients MUPS NR NR  
Morton et al. 
(2016) 
17 Patients MUS NR  NR  
Payne et al. (2015) 16 Patients MUS 10 female; 6 male Range 19-80 years 


















Table 6 Summary of health practitioner characteristics 
Author (date) Sample Population being treated as 
described in the study 
Gender Age 
Cowell et al. 
(2018a); Cowell et 
al. (2018b) 
10 Physiotherapists Non-specific chronic low back 
pain 
Seven male; three female Not reported (years working in MSK range 
3->14 years). 
Peters et al. (2011) 3 nurse therapists, 3 supervisors,  CFS/ME 
 
Nurses = 3 women;  
NR for supervisors 
NR for nurses and supervisors 
Dowrick et al. 
(2008) 
24 General practitioners MUS 16 female; 8 male Three aged under 35 year; 14 between 35 
and 50 years, and 7 over 50 years. 









Table 7 Description of the interventions delivered in the included studies 
Author (date) Population 
being treated 
as described 





Intervention duration Individual 
or group 
Burton et al. 
(2012) 
MUS GP with special interest ‘symptoms’ clinic.  The 
consultations were structured to first hear the patient’s 
experience of illness then to propose and 
negotiate constructive explanations of physical symptoms.  
These explanations were used as the basis for simple 
cognitive and behavioural actions to modify symptoms and 
their impact. 
GP  GP practice Four appointments; the first was of 1 
h duration and the subsequent three 
lasted 20 min 
Individual 
Chew-Graham 
et al. (2011) & 
Peters et al. 
(2011)  
CFS/ME (1) Pragmatic rehabilitation - a therapist facilitated CFS 
specific  self-management intervention, which shares 
features in common with CBT and GET, but which does 
not require a specialist CBT or physiotherapist to deliver it.  
(2)Supportive listening.  
Primary care 





90-minute session followed by 1-hour 
sessions on weeks 2, 4, 10, and 18. 
30-minute telephone calls on weeks 3, 
6, 8, 12, and 15. 
Individual 






Cognitive functional therapy (CFT). 
A biopsychosocial orientated behavioural intervention for 






Not reported.  Individual 
11 
 
clinical reasoning framework (MDCRF) (O’Sullivan et al., 
2018) 
Dowrick et al. 
(2008) & Peters 
et al. (2009) 
MUS Reattribution - a structured intervention, designed to 
provide a simple explanation of the mechanism of a 
patient's MUS, through negotiation and other features of 
patient centred communication, and to be delivered during 
routine consultations 
GP GP Practice The time since the index consultation 




MUPS CBT high intensity based on the cognitive-behavioural 








Weekly 1-hour appointments.  The 
median number of sessions attended 
was 17 (range 4–25). 
Individual 
CBT low intensity- based on the cognitive-behavioural 





Fortnightly with homework set 
between meetings. 
Individual 
Mindfulness based stress reduction Trained MBSR 
facilitator 
An 8-week programme for 2 hours 
per week. 
Group 
Graham (2007) MUPS Group counselling (humanistic) Group 
counsellor 
GP practice 1hr30minWeekly sessions for half a 
year  
Group 
Lewis et al. 
(2013) 
MUS CBT – based on the cognitive-behavioural model of 
MUPS.. 








diploma in CBT 
healthcare 
trust 
Morton et al.  
(2016) 
MUS Symptoms clinic intervention - a structured series of 
consultations. The SCI is comprised of four key elements: 
Recognition and validation of symptoms, Explanation of 
symptoms, Actions to manage symptoms and Learning. 
GP GP Practice 3 – 4 consultations over a period of 
six-eight week. First lasts 50 min, 
subsequent shorter (15–20 min) 
consultations. 
Individual 
Payne et al.  
(2015) 
MUS The BodyMind Approach (TBMA), based on a bio-










2h for 12 sessions over eight weeks 
and other communication over a 12 
month period. Total face to face 











Table 8 Quality assessment results for the included studies. 
Question (Yes/No/Can’t tell) Burton et al 
(2012) 
Chew-Graham et al 
(2011) & Peters et al 
(2011) 
Cowell et al. (2018a); 
(2018b) 
Dowrick et al 
(2008) 
Gerskowitch 
et al. (2015) 
Graham (2007) Lewis et al (2013) Morton et al 
(2016) 
Payne et al (2015) Peters et al 
(2008) 
Is the study qualitative research or does 
it provide qualitative data 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Is the study context and aims clearly 
described? 
Yes Yes Yes Yes  Yes Somewhat Yes 
 
Yes Somewhat, each 
element could have 
been clearer 
Yes 
Is there evidence of research reflexivity? No No Reflexivity mentioned in the 
methods but not obviously 
applied in the analysis. 
No No Yes Yes No Yes No 
Are the sampling methods clearly 
described and appropriate for the 
research question? 
Yes Yes – part of a trial 
 
Yes Yes – part of a 
trial 
Yes Yes Yes Yes – part of a 
trial 
No, it is unclear how 
many patients 
contributed data/ took 




Are the methods of data collection clearly 
described and appropriate to the 
research question?  
Yes Yes Yes Yes Yes Somewhat – not very 
detailed 




Is the method of analysis clearly 
described and appropriate to the 
research question? 
No – qualitative 
methods not 
described 
Yes Yes Yes Yes No – content analysis 
mentioned, details of 
how this was conducted 
not present 
Yes Yes – content 





Are the claims made supported by 
sufficient evidence (ie. Did the data 
provide sufficient depth, detail and 
richness)? 





Yes Yes Yes No – data was not very 
detailed or rich 
Yes No – only 




Assessment of quality Low Moderate Moderate Moderate Moderate Low High Moderate Low Moderate 
14 
 
Table 9 Summary of the key findings 
 Patients Health practitioners 
Valuable results from 
intervention 
participation or training 
Gaining support being validated Developing knowledge and skills around 
PPS Explanation 
Support for self-management 
Rewarding when patients engaged 
 
Facilitators Good relationships between patients 
and HPs 
Training and supervision 
Primary care or community setting 
 
Barriers Patient attitudes and beliefs Lack of confidence in their own skills and 
abilities to deal with PPS 
Poor relationship with HPs Patient attitudes and  beliefs 
HP attitudes and beliefs 
Resources constraints  
 
Adverse effects It ended Detrimental intervention consequences for 
patients 
Conflicts between HPs and patients, 
and HP lack of understanding 
Patient and Health practitioner emotions 
  
Supporting Materials  
 
Search methods 
A systematic search strategy was developed by a library information specialist (ASu) to 
identify this evidence relating to a primary care or community-based population; population 
terms were combined with terms that define the setting. A combination of free-text and 
thesaurus searching was used.  Published methodological search filters to limit results to 
qualitative studies were used where available (ISSG, 2019).  The qualitative research filter 
was combined with a geographic filter to identify UK studies only.  No other search limits 
were applied. The earliest mention of “medically unexplained symptoms” in the context of a 
specific syndrome in MEDLINE was 1980 (de Figueiredo, 1980) with the term being first 
used for a set of 'similar' conditions in 1985 (Slavney & Teitelbaum, 1985). Initial search 
results therefore covered the period from 1980 to July 2016, updated in February 2019, in the 
following databases MEDLINE via OvidSP, MEDLINE In-Process & Other Non-Indexed 
Citations & Epub Ahead of Print & MEDLINE ® without Revisions via OvidSP, Embase via 
Ovid SP, CINAHL via EBSCO, PsycINFO via OvidSP, Science Citation Index via Web of 
Science, Social Sciences Citation Index via Web of Science. Supplementary search methods, 
citation searching and reference list searching, were also undertaken to identify any further 
citations that may not have appeared in electronic databases.  
 
Search Strategy  
MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, Epub Ahead of Print, 
MEDLINE ® without Revisions via OvidSP  
1  medically unexplained symptom*.ti,ab. 
2  MUS.ti,ab.  
3  medically unexplained physical symptom*.ti,ab.  
4  MUPS.ti,ab. 
5  (unexplain* adj1 medical*).ti,ab.  
6  (unexplain* adj1 (sympt* or problem* or condition* or complain*)).ti,ab.  
7  ((non specific or nonspecific) adj2 (sympt* or problem* or condition* or complain*)).ti,ab.  
8  ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or problem* or 
condition* or complain*)).ti,ab.  
9  unexplained physical symptom*.ti,ab.  
10  (Persistent adj2 physical symptom*).ti,ab.  
11  distress syndrome.ti,ab.  
12  polydistress disorder.ti,ab. 
13  medically unexplained syndrome*.ti,ab.  
14  or/1-13  
Supporting information (anonymous) Click here to access/download;Supporting information
(anonymous);Supporting materials PPS.docx
15  (functional adj2 (disorder* or syndrome* or symptom* or pain*)).ti,ab.  
16  Fibromyalgia/  
17  fibromyalgi*.ti,ab.  
18  Fatigue Syndrome, Chronic/  
19  CFS.ti,ab.  
20  (chronic fatigue adj3 (syndrome* or disorder*)).ti,ab.  
21  myalgic encephalomyelitis.ti,ab.  
22  fatigue syndrome.ti,ab.  
23  Colonic Diseases, Functional/  
24  Irritable Bowel Syndrome/  
25  irritable bowel syndrome*.ti,ab.  
26  IBS.ti,ab.  
27  Temporomandibular Joint Dysfunction Syndrome/  
28  ((temporomandibular joint or TMJ) adj2 (disease* or disorder* or dysfunction*)).ti,ab.  
29  Myofascial Pain Syndromes/  
30  myofascial pain disorder*.ti,ab.  
31  Facial Neuralgia/  
32  atypical facial pain.ti,ab.  
33 facial pain syndrome*.ti,ab.  
34  Hyperventilation/  
35  hyperventilation.ti,ab.  
36  dysfunctional breathing.ti,ab.  
37  loin pain h?ematuria syndrome*.ti,ab.  
38  Muscle Weakness/  
39  functional weakness*.ti,ab.  
40  Movement Disorders/  
41  movement disorder*.ti,ab.  
42  (non-epileptic adj (attack* or seizure*)).ti,ab.  
43  Dysmenorrhea/  
44  dysmenorrhoea.ti,ab.  
45  neurasthen*.ti,ab.  
46  Neurasthenia/  
47  Multiple Chemical Sensitivity/  
48  multiple chemical sensitivity.ti,ab.  
49  idiopathic environmental intolerance.ti,ab.  
50  Tension-Type Headache/  
51  ((tension type or idiopathic or psychogenic) adj2 headache*).ti,ab.  
52  Neurocirculatory Asthenia/  
53  *Asthenia/  
54  chronic asthenia.ti,ab.  
55  functional atrial arrhythmia.ti,ab.  
56  Da Costa's Syndrome.ti,ab.  
57  effort syndrome.ti,ab.  
58      functional cardiovascular disease*.ti,ab.  
59  subacute asthenia.ti,ab.  
60  functional disturbance*.ti,ab.  
61  (symptom adj syndrome*).ti,ab.  
62  Post-Concussion Syndrome/  
63  (post concussi* syndrome* or post-concussi* syndrome*).ti,ab.  
64  or/15-63  
65  Psychophysiologic Disorders/  
66  ((psychosomatic or pyschophysiologic) adj (disorder* or syndrome* or symptom*)).ti,ab.  
67  briquet syndrome*.ti,ab.  
68  Psychosomatic Medicine/  
69  psychophysiologic*.ti,ab.  
70  psychosomat*.ti,ab.  
71  psychogen*.ti,ab.  
72  *Somatoform Disorders/  
73  somatic symptom*.ti,ab.  
74  Somatoform Disorder*.ti,ab.  
75  somati?at*.ti,ab.  
76  (somatic adj2 syndrome*).ti,ab.  
77  *Conversion Disorder/  
78  conversion disorder*.ti,ab.  
79  subjective health complaint*.ti,ab.  
80  cardiac neurosis.ti,ab.  
81  or/65-80 
82  (Habits/ or Tics/ or Tic Disorders/) and Cough/  
83  (chronic adj2 cough).ti,ab.  
84  (habit cough or tic cough).ti,ab.  
85  chronic pelvic pain*.ti,ab.  
86  chronic widespread pain.ti,ab.  
87  ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain*).ti,ab.  
88  NCCP.ti,ab.  
89  atypical chest pain*.ti,ab.  
90  *Low Back Pain/  
91  chronic low back pain*.ti,ab.  
92  *chronic pain/  
93  (chronic adj2 pain).ti,ab.  
94  regional pain.ti,ab.  
95  ((non ulcer or nonulcer or non-ulcer or functional) adj2 dyspepsia).ti,ab.  
96  or/82-95 
97  *Sexual Dysfunctions, Psychological/  
98  *Vaginismus/  
99  (psychological adj2 sexual dysfunction*).ti,ab.  
100  vaginismus.ti,ab.  
101  psycho-sexual dysfunction*.ti,ab.  
102  psychosexual dysfunction*.ti,ab.  
103  *Erectile Dysfunction/  
104  (impotence or erectile dysfunction).ti,ab.  
105  *Vulvodynia/  
106  vulvodynia.ti,ab.  
107  anorgasmia.ti,ab.  
108  or/97-107  
109  14 or 64 or 81 or 96 or 108  
110  exp Primary Health Care/  
111  exp Family Practice/ or exp General Practice/  
112 PHYSICIANS, FAMILY/  
113  FAMILY HEALTHCARE/  
114  NURSE PRACTITIONERS/  
115  ((family or community) adj (medic$ or doctor$ or physician$ or nurs$ or health)).ti,ab.  
116  ((general or family or nurs$) adj1 (practice$ or practitioner$)).ti,ab.  
117  (primary care or primary healthcare or primary health care or primary health service$ or 
homecare or care in the community).ti,ab.  
118  (GP$ or generalist$).ti,ab.  
119  Occupational Health/  
120  (occupational adj (health* or therap*)).ti,ab.  
121  or/110-120  
122  109 and 121  
 
Search Filter: 
● University of Texas School of Public Health. Search Filters for Various Databases: Ovid 
Medline - Qualitative studies. Available from: 
http://libguides.sph.uth.tmc.edu/search_filters/ovid_medline_filters [Accessed 7th April 
2017] combined with (AND) terms to identify UK studies: exp Great Britain/ OR (Britain or 
british or wales or welsh or Scottish or scots or Scotland or England or English or 
Birmingham or leeds or London or Liverpool or Manchester or Glasgow or Edinburgh or 
Cardiff or Belfast or UK or GB or aberdeen).ti,ab,in,hw. 
 
EMBASE via OvidSP 
1. medically unexplained symptom*.ti,ab.  
2. MUS.ti,ab.  
3. medically unexplained physical symptom*.ti,ab.  
4. MUPS.ti,ab.  
5. (unexplain* adj1 medical*).ti,ab.  
6. (unexplain* adj1 (sympt* or problem* or condition* or complain*)).ti,ab.  
7. ((non specific or nonspecific) adj2 (sympt* or problem* or condition* or 
complain*)).ti,ab. 
 
8. ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or 
problem* or condition* or complain*)).ti,ab. 
 
9. unexplained physical symptom*.ti,ab.  
10. (Persistent adj2 physical symptom*).ti,ab.  
11. distress syndrome.ti,ab.  
12. polydistress disorder.ti,ab.  
13. medically unexplained syndrome*.ti,ab.  
14. or/1-13  
15. (functional adj2 (disorder* or syndrome* or symptom* or pain*)).ti,ab.  
16. fibromyalgia/  
17. fibromyalgi*.ti,ab.  
18. chronic fatigue syndrome/  
19. CFS.ti,ab.  
20. (chronic fatigue adj3 (syndrome* or disorder*)).ti,ab.  
21. myalgic encephalomyelitis.ti,ab.  
22. fatigue syndrome.ti,ab.  
23. irritable colon/  
24. irritable bowel syndrome*.ti,ab.  
25. IBS.ti,ab.  
26. temporomandibular joint disorder/  
27. ((temporomandibular joint or TMJ) adj2 (disease* or disorder* or 
dysfunction*)).ti,ab. 
 
28. myofascial pain/  
29. myofascial pain disorder*.ti,ab.  
30. face pain/  
31. atypical facial pain.ti,ab.  
32. facial pain syndrome*.ti,ab.  
33. hyperventilation syndrome/ or hyperventilation/  
34. hyperventilation.ti,ab.  
35. dysfunctional breathing.ti,ab.  
36. loin pain h?ematuria syndrome*.ti,ab.  
37. muscle weakness/  
38. functional weakness*.ti,ab.  
39. motor dysfunction/  
40. movement disorder*.ti,ab.  
41. (non-epileptic adj (attack* or seizure*)).ti,ab.  
42. dysmenorrhea/  
43. dysmenorrhoea.ti,ab.  
44. neurasthenia/  
45. neurasthen*.ti,ab.  
46. multiple chemical sensitivity/  
47. multiple chemical sensitivity.ti,ab.  
48. idiopathic environmental intolerance.ti,ab.  
49. tension headache/  
50. ((tension type or idiopathic or psychogenic) adj2 headache*).ti,ab.  
51. cardiac anxiety/  
52. *asthenia/  
53. chronic asthenia.ti,ab.  
54. functional atrial arrhythmia.ti,ab.  
55. Da Costa's Syndrome.ti,ab.  
56. effort syndrome.ti,ab.  
57. functional cardiovascular disease*.ti,ab.  
58. subacute asthenia.ti,ab.  
59. functional disturbance*.ti,ab.  
60. (symptom adj syndrome*).ti,ab.  
61. postconcussion syndrome/  
62. (post concussi* syndrome* or post-concussi* syndrome*).ti,ab.  
63. or/15-62  
64. psychosomatic disorder/  
65. ((psychosomatic or pyschophysiologic) adj (disorder* or syndrome* or 
symptom*)).ti,ab. 
 
66. briquet syndrome*.ti,ab.  
67. psychosomatics/  
68. psychophysiologic*.ti,ab.  
69. psychosomat*.ti,ab.  
70. psychogen*.ti,ab.  
71. *somatoform disorder/  
72. somatic symptom*.ti,ab.  
73. Somatoform Disorder*.ti,ab.  
74. somati?at*.ti,ab.  
75. (somatic adj2 syndrome*).ti,ab.  
76. conversion disorder/  
77. conversion disorder*.ti,ab.  
78. subjective health complaint*.ti,ab.  
79. cardiac neurosis.ti,ab.  
80. or/64-79  
81. habit/ and coughing/  
82. tic/ and coughing/  
83. (chronic adj2 cough).ti,ab.  
84. (habit cough or tic cough).ti,ab.  
85. chronic pelvic pain*.ti,ab.  
86. chronic widespread pain.ti,ab.  
87. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain*).ti,ab. 
 
88. NCCP.ti,ab.  
89. atypical chest pain*.ti,ab.  
90. *low back pain/  
91. chronic low back pain*.ti,ab.  
92. *chronic pain/  
93. (chronic adj2 pain).ti,ab.  
94. regional pain.ti,ab.  
95. ((non ulcer or nonulcer or non-ulcer or functional) adj2 dyspepsia).ti,ab.  
96. or/81-95  
97. psychological aspect/ and sexual dysfunction/  
98. vaginism/  
99. (psychological adj2 sexual dysfunction*).ti,ab.  
100. vaginismus.ti,ab.  
101. psycho-sexual dysfunction*.ti,ab.  
102. psychosexual dysfunction*.ti,ab.  
103. *erectile dysfunction/  
104. (impotence or erectile dysfunction).ti,ab.  
105. vulvodynia.ti,ab.  
106. anorgasmia.ti,ab.  
107. or/97-106  
108. exp primary health care/  
109. exp general practice/ 
 
110. general practitioner/ 
 
111. family health/ 
 
112. nurse practitioner/ 
 
113. ((family or community) adj (medic$ or doctor$ or physician$ or nurs$ or 
health)).ti,ab. 
 
114. ((general or family or nurs$) adj1 (practice$ or practitioner$)).ti,ab. 
 
115. (primary care or primary healthcare or primary health care or primary health 
service$ or homecare or care in the community).ti,ab. 
 
116. (GP$ or generalist$).ti,ab. 
 
117. occupational health/ 
 




120. 107 and 119 




● McMaster University Health Information Research Unit. Search Strategies for EMBASE in 
Ovid Syntax: Qualitative (Best balance of sensitivity and specificity). Available from: 
http://hiru.mcmaster.ca/hiru/HIRU_Hedges_EMBASE_Strategies.aspx#Economics 
[Accessed 7th April 2017] combined with (AND) terms to identify UK studies: exp Great 
Britain/ OR (Britain or british or wales or welsh or Scottish or scots or Scotland or England or 
English or Birmingham or leeds or London or Liverpool or Manchester or Glasgow or 
Edinburgh or Cardiff or Belfast or UK or GB or aberdeen).ti,ab,in,hw. 
 
CINAHL via EBSCO 
S1 TI medically unexplained symptom* OR AB medically unexplained symptom*  
S2 TI MUS OR AB MUS  
S3 TI medically unexplained physical symptom* OR AB medically unexplained physical 
symptom*  
S4 TI MUPS OR AB MUPS 
S5 TI (unexplain* n1 medical*) OR AB (unexplain* n1 medical*) 
S6 TI ( (unexplain* n1 (sympt* or problem* or condition* or complain*)) ) OR AB ( 
(unexplain* n1 (sympt* or problem* or condition* or complain*)) )  
S7 TI ( ((non specific or nonspecific) n2 (sympt* or problem* or condition* or complain*)) ) OR 
AB ( ((non specific or nonspecific) n2 (sympt* or problem* or condition* or complain*)) )  
S8 TI ( ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or problem* 
or condition* or complain*)) ) OR AB ( ((unexplain* or inexpl*) and (health* or medical* or 
physical*) and (sympt* or problem* or condition* or complain*)) ) 
S9 TI unexplained physical symptom* OR AB unexplained physical symptom* 
S10 TI (Persistent n2 physical symptom*) OR AB (Persistent n2 physical symptom*) 
S11 TI distress syndrome OR AB distress syndrome 
S12 TI polydistress disorder OR AB polydistress disorder 
S13 TI medically unexplained syndrome* OR AB medically unexplained syndrome* 
S14 (MH "Medically Unexplained Symptoms") 
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR 
S13 OR S14 
S16 TI ( (functional n2 (disorder* or syndrome* or symptom* or pain*)) ) OR AB ( (functional n2 
(disorder* or syndrome* or symptom* or pain*)) ) 
S17 (MH "Fibromyalgia") 
S18 TI fibromyalgi* OR AB fibromyalgi*  
S19 (MH "Fatigue Syndrome, Chronic") 
S20 TI CFS OR AB CFS  
S21 TI ( (chronic fatigue n3 (syndrome* or disorder*)) ) OR AB ( (chronic fatigue n3 (syndrome* 
or disorder*)) ) 
S22 TI myalgic encephalomyelitis OR AB myalgic encephalomyelitis 
S23 TI fatigue syndrome OR AB fatigue syndrome 
S24 (MH "Colonic Diseases, Functional") 
S25 (MH "Irritable Bowel Syndrome") 
S26 TI irritable bowel syndrome* OR AB irritable bowel syndrome* 
S27 TI IBS OR AB IBS 
S28 (MH "Temporomandibular Joint Syndrome") 
S29 TI ( ((temporomandibular joint or TMJ) n2 (disease* or disorder* or dysfunction*)) ) OR AB 
( ((temporomandibular joint or TMJ) n2 (disease* or disorder* or dysfunction*)) ) 
S30 (MH "Myofascial Pain Syndromes")           
S31 TI myofascial pain disorder* OR AB myofascial pain disorder* 
S32 (MH "Facial Neuralgia")   
S33 TI atypical facial pain OR AB atypical facial pain 
S34 TI facial pain syndrome* OR AB facial pain syndrome* 
S35 (MH "Hyperventilation") 
S36 TI hyperventilation OR AB hyperventilation 
S37 TI dysfunctional breathing OR AB dysfunctional breathing 
S38 TI loin pain h?ematuria syndrome* OR AB loin pain h?ematuria syndrome* 
S39 (MH "Muscle Weakness") 
S40 TI functional weakness* OR AB functional weakness* 
S41 (MH "Movement Disorders")  
S42 TI movement disorder* OR AB movement disorder* 
S43 TI ( (non-epileptic n1 (attack* or seizure*) ) OR AB ( (non-epileptic n1 (attack* or seizure*) )         
S44 (MH "Dysmenorrhea")  
S45 TI dysmenorrhoea OR AB dysmenorrhoea 
S46 TI neurasthen* OR AB neurasthen* 
S47 (MH "Multiple Chemical Sensitivity") 
S48 TI multiple chemical sensitivity OR AB multiple chemical sensitivity 
S49 TI idiopathic environmental intolerance OR AB idiopathic environmental intolerance 
S50 (MH "Tension Headache") 
S51 TI ( ((tension type or idiopathic or psychogenic) n2 headache*) ) OR AB ( ((tension type or 
idiopathic or psychogenic) n2 headache*) )         
S52 (MM "Asthenia")  
S53 TI chronic asthenia OR AB chronic asthenia 
S54 TI functional atrial arrhythmia OR AB functional atrial arrhythmia   
S55 TI Da Costa's Syndrome OR AB Da Costa's Syndrome 
S56 TI effort syndrome OR AB effort syndrome 
S57 TI functional cardiovascular disease* OR AB functional cardiovascular disease* 
S58 TI subacute asthenia OR AB subacute asthenia 
S59 TI functional disturbance* OR AB functional disturbance* 
S60 TI (symptom n1 syndrome*) OR AB (symptom n1 syndrome*) 
S61 (MH "Postconcussion Syndrome")    
S62 TI ( (post concussi* syndrome* or post-concussi* syndrome*) ) OR AB ( (post concussi* 
syndrome* or post-concussi* syndrome*) ) 
S63 S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR 
S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 
OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48 OR S49 OR 
S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 
OR S62      
S64 (MH "Psychophysiologic Disorders")  
S65 TI ( ((psychosomatic or pyschophysiologic) n1 (disorder* or syndrome* or symptom*)) ) OR 
AB ( ((psychosomatic or pyschophysiologic) n1 (disorder* or syndrome* or symptom*)) )  
S66 TI briquet syndrome* OR AB briquet syndrome*  
S67 TI psychophysiologic* OR AB psychophysiologic*  
S68 TI psychosomat* OR AB psychosomat*  
S69 TI psychogen* OR AB psychogen*  
S70 (MM "Somatoform Disorders")  
S71 TI somatic symptom* OR AB somatic symptom*  
S72 TI somatoform disorder* OR AB somatoform disorder* 
S73 TI somati?at* OR AB somati?at*  
S74 TI (somatic n2 syndrome*) OR AB (somatic n2 syndrome*)  
S75 TI conversion disorder* OR AB conversion disorder*  
S76 TI subjective health complaint* OR AB subjective health complaint*  
S77 TI cardiac neurosis OR AB cardiac neurosis  
S78 S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR 
S75 OR S76 OR S77  
S79 (MH "Habits") AND (MH "Cough")  
S80 (MH "Tic") AND (MH "Cough")  
S81 TI (chronic n2 cough) OR AB (chronic n2 cough)  
S82 TI ( (habit cough or tic cough) ) OR AB ( (habit cough or tic cough) )  
S83 TI chronic pelvic pain* OR AB chronic pelvic pain*  
S84 TI chronic widespread pain OR AB chronic widespread pain  
S85 TI ( ((non cardiac or noncardiac or non specific or nonspecific) n2 chest pain*) ) OR AB ( 
((non cardiac or noncardiac or non specific or nonspecific) n2 chest pain*) )  
S86 TI NCCP OR AB NCCP  
S87 TI atypical chest pain* OR AB atypical chest pain*  
S88 (MM "Low Back Pain")  
S89 TI chronic low back pain* OR AB chronic low back pain*  
S90 (MM "Chronic Pain")  
S91 TI (chronic n2 pain) OR AB (chronic n2 pain)  
S92 TI regional pain OR AB regional pain  
S93 TI ( ((non ulcer or nonulcer or non-ulcer or functional) n2 dyspepsia) ) OR AB ( ((non ulcer 
or nonulcer or non-ulcer or functional) n2 dyspepsia) )  
S94 S79 OR S80 OR S81 OR S82 OR S83 OR S84 OR S85 OR S86 OR S87 OR S88 OR S89 OR 
S90 OR S91 OR S92 OR S93  
S95 (MM "Psychosexual Disorders")  
S96 TI (psychological n2 sexual dysfunction*) OR AB (psychological n2 sexual dysfunction*) 
S97 TI vaginismus OR AB vaginismus  
S98 TI psycho-sexual dysfunction* OR AB psycho-sexual dysfunction*  
S99 TI psychosexual dysfunction* OR AB psychosexual dysfunction*  
S100 (MM "Impotence")  
S101 TI ( (impotence or erectile dysfunction) ) OR AB ( (impotence or erectile dysfunction) )  
S102 TI vulvodynia OR AB vulvodynia  
S103 TI anorgasmia OR AB anorgasmia  
S104 S95 OR S96 OR S97 OR S98 OR S99 OR S100 OR S101 OR S102 OR S103  
S105 S15 OR S63 OR S94 OR S104  
S106 (MH "Primary Health Care")  
S107 (MH "Family Practice")  
S108 (MH "Physicians, Family")  
S109 (MH "Nurse Practitioners")  
S110 TI ( ((family or community) n1 (medic$ or doctor$ or physician$ or nurs$ or health)) ) OR 
AB ( ((family or community) n1 (medic$ or doctor$ or physician$ or nurs$ or health)) ) 
S111 TI ( ((general or family or nurs$) n1 (practice$ or practitioner$)) ) OR AB ( ((general or 
family or nurs$) n1 (practice$ or practitioner$)) )  
S112 TI ( (primary care or primary healthcare or primary health care or primary health service$ or 
homecare or care in the community) ) OR AB ( (primary care or primary healthcare or primary health 
care or primary health service$ or homecare or care in the community) )  
S113 TI ( (GP$ or generalist$) ) OR AB ( (GP$ or generalist$) )  
S114 (MH "Occupational Health")  
S115 TI ( (occupational n1 (health* or therap*)) ) OR AB ( (occupational n1 (health* or therap*)) )  
S116 S106 OR S107 OR S108 OR S109 OR S110 OR S111 OR S112 OR S113 OR S114 OR S115  
S117 S105 AND S116  
 
Search Filter: 
● University of Washington Health Sciences Library. Finding Qualitative Research Articles: 
CINAHL. Available from: http://guides.lib.uw.edu/c.php?g=99112&p=642298 [Accessed 7th 
April 2017] combined with (AND) terms to identify UK studies:  
(MH "Great Britain") OR (Britain or british or wales or welsh or Scottish or scots or Scotland 
or England or English or Birmingham or leeds or London or Liverpool or Manchester or 
Glasgow or Edinburgh or Cardiff or Belfast or UK or GB or aberdeen) 
 
PyscINFO via OvidSP 
1. medically unexplained symptom*.ti,ab.  
2. MUS.ti,ab.  
3. medically unexplained physical symptom*.ti,ab.  
4. MUPS.ti,ab.  
5. (unexplain* adj1 medical*).ti,ab.  
6. (unexplain* adj1 (sympt* or problem* or condition* or complain*)).ti,ab.  
7. ((non specific or nonspecific) adj2 (sympt* or problem* or condition* or 
complain*)).ti,ab. 
 
8. ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or 
problem* or condition* or complain*)).ti,ab. 
 
9. unexplained physical symptom*.ti,ab.  
10. (Persistent adj2 physical symptom*).ti,ab.  
11. distress syndrome.ti,ab.  
12. polydistress disorder.ti,ab.  
13. medically unexplained syndrome*.ti,ab.  
14. or/1-13  
15. (functional adj2 (disorder* or syndrome* or symptom* or pain*)).ti,ab.  
16. exp Fibromyalgia/  
17. fibromyalgi*.ti,ab.  
18. Chronic Fatigue Syndrome/  
19. CFS.ti,ab.  
20. (chronic fatigue adj3 (syndrome* or disorder*)).ti,ab.  
21. myalgic encephalomyelitis.ti,ab.  
22. fatigue syndrome.ti,ab.  
23. Irritable Bowel Syndrome/  
24. irritable bowel syndrome*.ti,ab.  
25. IBS.ti,ab.  
26. ((temporomandibular joint or TMJ) adj2 (disease* or disorder* or 
dysfunction*)).ti,ab. 
 
27. exp Syndromes/ and Myofascial Pain/  
28. myofascial pain disorder*.ti,ab.  
29. atypical facial pain.ti,ab.  
30. facial pain syndrome*.ti,ab.  
31. Hyperventilation/  
32. hyperventilation.ti,ab.  
33. dysfunctional breathing.ti,ab.  
34. loin pain h?ematuria syndrome*.ti,ab.  
35. functional weakness*.ti,ab.  
36. Movement Disorders/  
37. movement disorder*.ti,ab.  
38. (non-epileptic adj (attack* or seizure*)).ti,ab.  
39. Dysmenorrhea/  
40. dysmenorrhoea.ti,ab.  
41. neurasthen*.ti,ab.  
42. Neurasthenia/  
43. multiple chemical sensitivity.ti,ab.  
44. idiopathic environmental intolerance.ti,ab.  
45. exp Muscle Contraction Headache/  
46. ((tension type or idiopathic or psychogenic) adj2 headache*).ti,ab.  
47. *Asthenia/  
48. chronic asthenia.ti,ab.  
49. functional atrial arrhythmia.ti,ab.  
50. Da Costa's Syndrome.ti,ab.  
51. effort syndrome.ti,ab.  
52. functional cardiovascular disease*.ti,ab.  
53. subacute asthenia.ti,ab.  
54. functional disturbance*.ti,ab.  
55. (symptom adj syndrome*).ti,ab.  
56. (post concussi* syndrome* or post-concussi* syndrome*).ti,ab.  
57. or/15-56  
58. Somatoform Disorders/  
59. ((psychosomatic or pyschophysiologic) adj (disorder* or syndrome* or 
symptom*)).ti,ab. 
 
60. briquet syndrome*.ti,ab.  
61. Psychosomatic Medicine/  
62. psychophysiologic*.ti,ab.  
63. psychosomat*.ti,ab.  
64. psychogen*.ti,ab.  
65. somatic symptom*.ti,ab.  
66. Somatoform Disorder*.ti,ab.  
67. somati?at*.ti,ab.  
68. (somatic adj2 syndrome*).ti,ab.  
69. *Conversion Disorder/  
70. conversion disorder*.ti,ab.  
71. subjective health complaint*.ti,ab.  
72. cardiac neurosis.ti,ab.  
73. or/58-72  
74. (chronic adj2 cough).ti,ab.  
75. (habit cough or tic cough).ti,ab.  
76. chronic pelvic pain*.ti,ab.  
77. chronic widespread pain.ti,ab.  
78. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain*).ti,ab. 
 
79. NCCP.ti,ab.  
80. atypical chest pain*.ti,ab.  
81. *Back Pain/  
82. chronic low back pain*.ti,ab.  
83. *Chronic Pain/  
84. (chronic adj2 pain).ti,ab.  
85. regional pain.ti,ab.  
86. ((non ulcer or nonulcer or non-ulcer or functional) adj2 dyspepsia).ti,ab.  
87. or/74-86  
88. *Sexual Function Disturbances/  
89. (psychological adj2 sexual dysfunction*).ti,ab.  
90. *Vaginismus/  
91. vaginismus.ti,ab.  
92. psycho-sexual dysfunction*.ti,ab.  
93. psychosexual dysfunction*.ti,ab.  
94. *Erectile Dysfunction/  
95. (impotence or erectile dysfunction).ti,ab.  
96. vulvodynia.ti,ab.  
97. anorgasmia.ti,ab.  
98. or/88-97  
99. 14 or 57 or 73 or 87 or 98  
100. exp Primary Health Care/  
101. exp General Practitioners/  
102. Family Physicians/  
103. Family Medicine/  
104. ((family or community) adj (medic$ or doctor$ or physician$ or nurs$ or 
health)).ti,ab. 
 
105. ((general or family or nurs$) adj1 (practice$ or practitioner$)).ti,ab.  
106. (primary care or primary healthcare or primary health care or primary health 
service$ or homecare or care in the community).ti,ab. 
 
107. (GP$ or generalist$).ti,ab.  
108. Occupational Health/  
109. (occupational adj (health* or therap*)).ti,ab.  
110. or/100-109  




● The University of Texas School of Public Health. Search Filters for Various Databases: Ovid 
PsycINFO (Qualitative studies). Available from: 
http://libguides.sph.uth.tmc.edu/search_filters/ovid_psycinfo_filters [Accessed 7th April 
2017] combined with (AND) terms to identify UK studies: (Britain or british or wales or 
welsh or Scottish or scots or Scotland or England or English or Birmingham or leeds or 
London or Liverpool or Manchester or Glasgow or Edinburgh or Cardiff or Belfast or UK or 
GB or aberdeen).ti,ab,in,hw. 
 
The Cochrane Library (DARE, CDSR, CENTRAL, HTA, NHS EED) 
#1 medically unexplained symptom*:ti or medically unexplained symptom*:ab  
#2 MUS:ti or MUS:ab  
#3 medically unexplained physical symptom*:ti or medically unexplained physical symptom*:ab  
#4 MUPS:ti or MUPS:ab  
#5 (unexplain* near/1 medical*):ti or (unexplain* near/1 medical*):ab  
#6 (unexplain* near/1 (sympt* or problem* or condition* or complain*)):ti or (unexplain* near/1 
(sympt* or problem* or condition* or complain*))  
#7 ((non specific or nonspecific) near/2 (sympt* or problem* or condition* or complain*)):ti or 
((non specific or nonspecific) near/2 (sympt* or problem* or condition* or complain*)):ab  
#8 ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or problem* or 
condition* or complain*)):ti or ((unexplain* or inexpl*) and (health* or medical* or physical*) and 
(sympt* or problem* or condition* or complain*)):ab  
#9 unexplained physical symptom*:ti or unexplained physical symptom*:ab  
#10 (Persistent near/2 physical symptom*):ti or (Persistent near/2 physical symptom*):ab  
#11 distress syndrome:ti or distress syndrome:ab  
#12 polydistress disorder:ti or polydistress disorder:ab  
#13 medically unexplained syndrome*:ti or medically unexplained syndrome*:ab  
#14 {or #1-#13}  
#15 (functional near/2 (disorder* or syndrome* or symptom* or pain*)):ti or (functional near/2 
(disorder* or syndrome* or symptom* or pain*)):ab  
#16 MeSH descriptor: [Fibromyalgia] explode all trees 
#17 fibromyalgi*:ti or fibromyalgi*:ab  
#18 MeSH descriptor: [Fatigue Syndrome, Chronic] explode all trees 
#19 CFS:ti or CFS:ab  
#20 (chronic fatigue near/3 (syndrome* or disorder*)):ti or (chronic fatigue near/3 (syndrome* or 
disorder*)):ab  
#21 myalgic encephalomyelitis:ti or myalgic encephalomyelitis:ab  
#22 fatigue syndrome:ti or fatigue syndrome:ab  
#23 MeSH descriptor: [Colonic Diseases, Functional] explode all trees 
#24 MeSH descriptor: [Irritable Bowel Syndrome] explode all trees 
#25 irritable bowel syndrome*:ti or irritable bowel syndrome*:ab  
#26 IBS:ti or IBS:ab  
#27 MeSH descriptor: [Temporomandibular Joint Dysfunction Syndrome] explode all trees 
#28 ((temporomandibular joint or TMJ) near/2 (disease* or disorder* or dysfunction*)):ti or 
((temporomandibular joint or TMJ) near/2 (disease* or disorder* or dysfunction*)):ab  
#29 MeSH descriptor: [Myofascial Pain Syndromes] explode all trees 
#30 myofascial pain disorder*:ti or myofascial pain disorder*:ab  
#31 MeSH descriptor: [Facial Neuralgia] explode all trees 
#32 atypical facial pain:ti or atypical facial pain:ab  
near/2 (disorder* or syndrome* or symptom* or pain*)):ab  
#16 MeSH descriptor: [Fibromyalgia] explode all trees 
#17 fibromyalgi*:ti or fibromyalgi*:ab  
#18 MeSH descriptor: [Fatigue Syndrome, Chronic] explode all trees 
#19 CFS:ti or CFS:ab  
#20 (chronic fatigue near/3 (syndrome* or disorder*)):ti or (chronic fatigue near/3 (syndrome* or 
disorder*)):ab  
#21 myalgic encephalomyelitis:ti or myalgic encephalomyelitis:ab  
#22 fatigue syndrome:ti or fatigue syndrome:ab  
#23 MeSH descriptor: [Colonic Diseases, Functional] explode all trees 
#24 MeSH descriptor: [Irritable Bowel Syndrome] explode all trees 
#25 irritable bowel syndrome*:ti or irritable bowel syndrome*:ab  
#26 IBS:ti or IBS:ab  
#27 MeSH descriptor: [Temporomandibular Joint Dysfunction Syndrome] explode all trees 
#28 ((temporomandibular joint or TMJ) near/2 (disease* or disorder* or dysfunction*)):ti or 
((temporomandibular joint or TMJ) near/2 (disease* or disorder* or dysfunction*)):ab  
#29 MeSH descriptor: [Myofascial Pain Syndromes] explode all trees 
#30 myofascial pain disorder*:ti or myofascial pain disorder*:ab  
#31 MeSH descriptor: [Facial Neuralgia] explode all trees 
#32 atypical facial pain:ti or atypical facial pain:ab  
#33 facial pain syndrome*:ti or facial pain syndrome*:ab  
#34 MeSH descriptor: [Hyperventilation] explode all trees 
#35 hyperventilation:ti or hyperventilation:ab  
#36 dysfunctional breathing:ti or dysfunctional breathing:ab  
#37 loin pain h?ematuria syndrome*:ti or loin pain h?ematuria syndrome*:ab  
#38 MeSH descriptor: [Muscle Weakness] explode all trees 
#39 functional weakness*:ti or functional weakness*:ab  
#40 MeSH descriptor: [Movement Disorders] this term only 
#41 movement disorder*:ti or movement disorder*:ab  
#42 (non-epileptic next (attack* or seizure*)):ti or (non-epileptic next (attack* or seizure*)):ab  
#43 MeSH descriptor: [Dysmenorrhea] explode all trees 
#44 dysmenorrhoea:ti or dysmenorrhoea:ab  
#45 neurasthen*:ti or neurasthen*:ab  
#46 MeSH descriptor: [Neurasthenia] explode all trees 
#47 MeSH descriptor: [Multiple Chemical Sensitivity] explode all trees 
#48 multiple chemical sensitivity:ti or multiple chemical sensitivity:ab  
#49 idiopathic environmental intolerance:ti or idiopathic environmental intolerance:ab  
#50 MeSH descriptor: [Tension-Type Headache] explode all trees 
#51 ((tension type or idiopathic or psychogenic) near/2 headache*):ti or ((tension type or 
idiopathic or psychogenic) near/2 headache*):ab  
#52 MeSH descriptor: [Neurocirculatory Asthenia] explode all trees 
#53 MeSH descriptor: [Asthenia] explode all trees 
#54 chronic asthenia:ti or chronic asthenia:ab  
#55 functional atrial arrhythmia:ti or functional atrial arrhythmia:ab  
#56 Da Costa's Syndrome:ti or Da Costa's Syndrome:ab  
#57 effort syndrome:ti or effort syndrome:ab  
#58 functional cardiovascular disease*:ti or functional cardiovascular disease*:ab  
#59 subacute asthenia:ti or subacute asthenia:ab  
#60 functional disturbance*:ti or functional disturbance*:ab  
#61 (symptom next syndrome*):ti or (symptom next syndrome*):ab  
#62 MeSH descriptor: [Post-Concussion Syndrome] explode all trees 
#63 (post concussi* syndrome* or post-concussi* syndrome*):ti or (post concussi* syndrome* or 
post-concussi* syndrome*):ab  
#64 {or #15-#63}  
#65 MeSH descriptor: [Psychophysiologic Disorders] explode all trees 
#66 ((psychosomatic or pyschophysiologic) next (disorder* or syndrome* or symptom*)):ti or 
((psychosomatic or pyschophysiologic) next (disorder* or syndrome* or symptom*)):ab  
#67 briquet syndrome*:ti or briquet syndrome*:ab  
#68 MeSH descriptor: [Psychosomatic Medicine] explode all trees 
#69 psychophysiologic*:ti or psychophysiologic*:ab  
#70 psychosomat*:ti or psychosomat*:ab  
#71 psychogen*:ti or psychogen*:ab  
#72 MeSH descriptor: [Somatoform Disorders] explode all trees 
#73 somatic symptom*:ti or somatic symptom*:ab  
#74 Somatoform Disorder*:ti or Somatoform Disorder*:ab  
#75 somati?at*:ti or somati?at*:ab  
#76 (somatic near/2 syndrome*):ti or (somatic near/2 syndrome*):ab  
#77 MeSH descriptor: [Conversion Disorder] explode all trees 
#78 conversion disorder*:ti or conversion disorder*:ab  
#79 subjective health complaint*:ti or subjective health complaint*:ab  
#80 cardiac neurosis:ti or cardiac neurosis:ab  
#81 {or #65-#80}  
#82 MeSH descriptor: [Habits] this term only 
#83 MeSH descriptor: [Tics] explode all trees 
#84 MeSH descriptor: [Tic Disorders] explode all trees 
#85 {or #82-#84}  
#86 MeSH descriptor: [Cough] this term only 
#87 #85 and #86  
#88 (chronic near/2 cough):ti or (chronic near/2 cough):ab  
#89 (habit cough or tic cough):ti or (habit cough or tic cough):ab  
#90 chronic pelvic pain*:ti or chronic pelvic pain*:ab  
#91 chronic widespread pain:ti or chronic widespread pain:ab  
#92 ((non cardiac or noncardiac or non specific or nonspecific) near/2 chest pain*):ti or ((non 
cardiac or noncardiac or non specific or nonspecific) near/2 chest pain*):ab  
#93 NCCP:ti or NCCP:ab  
#94 atypical chest pain*:ti or atypical chest pain*:ab  
#95 MeSH descriptor: [Low Back Pain] this term only 
#96 chronic low back pain*:ti or chronic low back pain*:ab  
#97 MeSH descriptor: [Chronic Pain] this term only 
#98 (chronic near/2 pain):ti or (chronic near/2 pain):ab  
#99 regional pain:ti or regional pain:ab  
#100 ((non ulcer or nonulcer or non-ulcer or functional) near/2 dyspepsia):ti ((non ulcer or nonulcer 
or non-ulcer or functional) near/2 dyspepsia):ab  
#101 {or #87-#100}  
#102 MeSH descriptor: [Sexual Dysfunctions, Psychological] this term only 
#103 (psychological near/2 sexual dysfunction*):ti or (psychological near/2 sexual 
dysfunction*):ab  
#104 MeSH descriptor: [Vaginismus] explode all trees 
#105 vaginismus:ti or vaginismus:ab  
#106 psycho-sexual dysfunction*:ti or psycho-sexual dysfunction*:ab  
#107 psychosexual dysfunction*:ti or psychosexual dysfunction*:ab  
#108 MeSH descriptor: [Erectile Dysfunction] this term only 
#109 (impotence or erectile dysfunction):ti or (impotence or erectile dysfunction):ab  
#110 MeSH descriptor: [Vulvodynia] explode all trees 
#111 vulvodynia:ti or vulvodynia:ab  
#112 anorgasmia:ti or anorgasmia:ab  
#113 {or #102-#112}  
#114 #14 or #64 or #81 or #101 or #113  
#115 MeSH descriptor: [Primary Health Care] explode all trees 
#116 MeSH descriptor: [Family Practice] explode all trees 
#117 MeSH descriptor: [General Practice] explode all trees 
#118 MeSH descriptor: [Physicians, Family] explode all trees 
#119 FAMILY HEALTHCARE  
#120 MeSH descriptor: [Nurse Practitioners] explode all trees 
#121 ((family or community) next (medic* or doctor* or physician* or nurs* or health)):ti or 
((family or community) next (medic* or doctor* or physician* or nurs* or health)):ab  
#122 ((general or family or nurs*) next/1 (practice* or practitioner*)):ti or ((general or family or 
nurs*) next/1 (practice* or practitioner*)):ab  
#123 (primary care or primary healthcare or primary health care or primary health service* or 
homecare or care in the community):ti or (primary care or primary healthcare or primary health care 
or primary health service* or homecare or care in the community):ab  
#124 (GP* or generalist*):ti or (GP* or generalist*):ab  
#125 MeSH descriptor: [Occupational Health] explode all trees 
#126 (occupational next (health* or therap*)):ti or (occupational next (health* or therap*)):ab  
#127 {or #115-#126}  
#128 #114 and #127 
 
Search Filters: 
No search filters were applied to The Cochrane Library searches. 
 
Science Citation Index & Social Sciences Citation Index via Web of Science 
#1       TOPIC: (((medically unexplained symptom* or MUS or medically unexplained physical 
symptom* or MUPS)))  
#2       TOPIC: ((unexplain*) NEAR/1 (medical* or sympt* or problem* or condition* or complain*)) 
#3       TOPIC: (((non-specific or nonspecific) NEAR/2 (sympt* or problem* or condition* or 
complain*)))  
#4       TOPIC: ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or 
problem* or condition* or complain*))  
#5       TOPIC: ((unexplained physical symptom* or (persistent NEAR/2 symptom*) or distress 
syndrome or polydistress disorder or medically unexplained syndrome*)) 
#6       TOPIC: ((functional) NEAR/2 (disorder* or syndrome* or symptom* or pain*)) 
#7       TOPIC: ((fibromyalgi* or CFS or (fatigue NEAR/3 syndrome* or disorder*) or myalgic 
encephalomyelitis or irritable bowel syndrome* or IBS)) 
#8       TOPIC: ((temporomandibular or TMJ) NEAR/2 (disease* or disorder* or dysfunction*)) 
#9       TOPIC: ((myofascial pain disorder* or atypical facial pain or facial pain syndrome* or 
hyperventilation or dysfunctional breathing or loin pain h?ematuria syndrome* or functional 
weakness* or movement disorder*)) 
#10     TOPIC: ((non-epileptic NEAR attack* or seizure*) or (dysmenorrhoea or neurasthen* or 
multiple chemical sensitivity or idiopathic environmental intolerance)) 
#11     TOPIC: ((tension or idiopathic or psychogenic) NEAR/2 (headache*)) 
#12     TOPIC: ((chronic asthenia or functional atrial arrhythmia or da costa's syndrome or effort 
syndrome or functional cardiovascular disease* or subacute asthenia or functional disturbance* or 
(symptom NEAR syndrome*))) 
#13     TOPIC: ((post concussi* syndrome* or post-concussi* syndrome*)) 
#14     TOPIC: ((psychosomatic or pyschophysiologic) NEAR/2 (disorder* or syndrome* or 
symptom*)) 
#15     TOPIC: ((briquet syndrome* or pyschophysiologic* or psychosomatic* or psychogen* or 
somatic symptom* or somati?at*)) 
#16     TOPIC: (((somatic NEAR/2 syndrome*) or (conversion disorder* or subjective health 
complaint* or cardiac neurosis))) 
#17     TOPIC: ((chronic NEAR/2 cough) or (habit cough or tic cough or chronic pelvic pain* or 
chronic widespread pain))     
#18     TOPIC: ((non-cardiac or noncardiac or non-specific or nonspecific) NEAR/2 (chest NEAR 
pain*)) 
#19     TOPIC: (NCCP or atypical chest pain* or chronic low back pain* or (chronic NEAR/2 pain) or 
regional pain) 
#20    TOPIC: ((non-ulcer or nonulcer or functional) NEAR/2 dyspepsia) 
#21    TOPIC: ((pyschological NEAR/2 sexual NEAR dysfunction*) or vaginismus or psycho-sexual 
dysfunction* or pyschosexual dysfunction* or impotence or erectile dysfunction or vulvodynia or 
anorgasmia)   
#22    #21 OR #20 OR #19 OR #18 OR #17 OR #16 OR #15 OR #14 OR #13 OR #12 OR #11 OR 
#10 OR #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1 
#23    TOPIC: ((family or community) NEAR (medic* or doctor* or physician* or nurs* or health))   
#24    TOPIC: ((general or family or nurs*) NEAR/1 (practice* or practitioner*))  
#25    TOPIC: ((primary care or primary healthcare or primary health care or primary health service* 
or homecare or care in the community))  
#26    TOPIC: (GP or GPs or generalist*)  
#27    TOPIC: (((occupational) NEAR (health* or therap*)))  
#28    #27 OR #26 OR #25 OR #24 OR #23  
#29    #28 AND #22 
 
Search Filters: 
Methodological search filters are not available for Web of Science, therefore the following terms were 
combined with the above search strategy using the operator “AND” to identify qualitative research. 
● TOPIC=(((("semi-structured" or semistructured or unstructured or informal or "in-depth" or 
indepth or "face-to-face" or structured or guide) NEAR/3 (interview* or discussion* or 
questionnaire*))) or (focus group* or qualitative or ethnograph* or fieldwork or "field work" 
or "key informant")) ] combined with (AND) terms to identify UK studies: TOPIC=((Britain 
or british or wales or welsh or Scottish or scots or Scotland or England or English or 
Birmingham or leeds or London or Liverpool or Manchester or Glasgow or Edinburgh or 
























Table S1  Thematic synthesis of evidence from patients 
Theme / Review 
Finding 












Positive factors relating to behavioural interventions as reported by patients / What did you gain from 
being referred to a behavioural intervention. 







6 studies, in general the 
studies were moderately 
well done.  The finding 
was seen across most of 
Validation 
Empathy  
Being listened to 
Theme / Review 
Finding 
















the studies in the synthesis 
and across different 
intervention formats and 
facilitators. Included 
studies with thick** data. 












2 studies, both of moderate 
quality, and including 
thick data.  Evidence came 
from different intervention 
types, and different 
facilitators. Coherent data 


















4 studies of moderate to 
low quality.  Evidence 
came from different 
settings. However there 
were limited rich data. The 
data appeared to be 








family and friends 
Graham (2007) 
Theme / Review 
Finding 























2 studies, one moderate 
quality with rich data, one 
low quality with thin data. 
Data were specific to 
group interventions. 
Coherent data across the 
studies. 





Factors reported as important, wanted or expected in behavioural interventions 
Balance between psychological and 
physical elements 
Burton (2012) Very low 
confidence 
1 one study of low quality 





1 study of moderate 
quality with thick data,* 
Other factors such as Diet / nutrition 





1 study of moderate 
quality with thick data.* 




1 study of moderate 
quality with thick data.* 
More consultation time Burton (2012) Very low 
confidence 
1 one study of low quality 
with thin data.*   
More investigations Peters (2009) Low 
confidence 
1 study of moderate 
quality with thick data.* 
Explanation Specialist 







2 studies, both of moderate 
quality with thick data. 
Data evident across 
different formats, and 
different facilitators.  
Explanation of the 
symptoms 
Theme / Review 
Finding 
















the patient and 
symptoms 
Reassurance Peters (2009) Low 
confidence 
1 study of moderate 













2 studies, both of moderate 
quality with thick data. 
Data evident across 
different formats, and 
different facilitators.  
Coherent data across the 
studies. 
Support for learning 
What patients didn’t like about (being referred to) behavioural interventions 
It made things 





Frustration – things 






3 studies of moderate 
quality.  Coherence is 
unclear as findings within 
the theme are diverse, 
thick data, consistent 
across different formats 
and facilitators 








Inflexibility of the 






Theme / Review 
Finding 


















Peters (2009) Low 
confidence. 
2 studies, both moderate 
quality, only one with 
thick data.  Specific to, GP 
delivered, individual 
interventions. Coherent 
data across the studies. 
Feeling of being 
blamed by the GP 
Morton (2016) 
It ended A feeling of loss 
when the 
intervention ends / 






1 study of moderate 
quality with thick data.* 
This finding was only seen 
in the one included study 
of patients with CFS and 












1 study of moderate 
quality with thick data.*  
This finding was only seen 
in the one included study 
of patients with CFS and 
may only be specific to 
this group. 
Patients felt the 









Barriers – why patients didn’t want behavioural interventions / or couldn’t engage with them 
Theme / Review 
Finding 












Lack of choice Lack of information 






1 study of moderate 
quality with thick data.* 





4 studies, three of 
moderate quality, one low 
quality, three with thick 
data, across different 
intervention formats and 
facilitators.  Coherent data 




GPs attention from 
other problems (so 









HPs, with patients 












1 study of moderate 
quality with thick data.* 
HPs lack of 
knowledge / skill 
GPs are unskilled at 
treating 
Peters (2009) Moderate 
confidence 
2 studies, both moderate 
quality and with thick data, 
Theme / Review 
Finding 

















intervention formats and 
facilitators. Coherent data 
across the studies. 
NTs are novices. Peters (2011) 
Patients beliefs 
that you should 
deal with it 
yourself 
Patients belief that 
they should self-
manage 
Peters (2009) Low 
confidence 
1 study of moderate 
quality with thick data.* 
Specific to a GP delivered 
intervention. Inappropriate to 
discuss psychosocial 
problems (with GP) 
Peters (2009) 




*Where only one study relates to a finding it is not possible to assess whether the finding would remain across 
other settings or assesses the coherence of the finding. 
**Thick data describes observed social actions and assigns purpose and intentionality to these actions, by way of a clear 
description of the context. Thin data can be regarded as superficial and does not explore underlying meanings. 
Confidence in each review finding was judged as high: It is highly likely that the review finding is a reasonable 
representation of the phenomenon of interest; moderate: It is likely that the review finding is a reasonable representation 
of the phenomenon of interest; low: It is possible that the review finding is a reasonable representation of the 
phenomenon of interest; or very low: it is not clear whether the review finding is a reasonable representation of the 
phenomenon of interest.   
 





Sub-themes / Findings Studies 
contributing 








Positive factors relating to behavioural interventions as reported by health professionals / What did you gain from 
















3 studies, of moderate quality, 
including thick** data.  
Evidence came from different 
intervention types with 
different facilitators.  Coherent 
data across the studies. 
Therapist peer support 
Increased GPs awareness and 
altered perceptions 




skill of the HP 
Learning and applying boundaries 
of their role 
Peters (2011) High 
confidence 
4 studies, one high quality, 
three of moderate quality.  All 
four including thick data. 
Evidence came from different 
intervention types with 
different facilitators.  Coherent 
data across the studies. 
Flexibility of the therapist Peters (2011); 
Lewis (2013) 












Learning how to build a patient-











Secondary care may support a 





2 studies, both of moderate 
quality, both including thick 
data.  Evidence came from 
different intervention types 
with different facilitators.  
Coherent data across the 
studies. 




Primary care allowed a more 
tailored approach 
Peters (2011) 
Being in patients’ homes was 





Rewarding when patients 









3 studies, one high quality, two 
of moderate quality, including 
thick data.  Evidence came 
from different intervention 
types with different facilitators.  
Coherent data across the 
studies. 
What did not help or were detrimental to the patients or delivery of the intervention 
When HPs felt 
they were a 
novice or did 
not have the 
required skill 
levels. 










3 studies, one high quality, two 
of moderate quality, including 
thick data.  Evidence came 
from different intervention 
types with different facilitators.  
Coherent data across the 
studies. Anxiety due to lack of training / 
knowledge 
Lewis (2013) 
Unfamiliarity with PPS Lewis (2013) 
No specific PPS model to work 
with 
Lewis (2013) 
Not as comfortable with mental 
health aspects of the interventions 
(as physical health) 
Peters (2011) 
Not dealing well with failure Peters (2011) 
When HPs 
struggled to 
deal with their 
own or patient 
emotions 
Pessimism (from HP) about 
dealing with PPS 
Lewis (2013) Moderate 
confidence 
2 studies, both of moderate 
quality, both including thick 
data.  Evidence came from 
different intervention types 
with different facilitators.  
Coherent data across the 
studies. 







to the patients. 
NTs worries about the 
intervention’s consequences 
Peters (2011) Moderate 
confidence 
2 studies, both of moderate 
quality, both including thick 
data.  Evidence came from 
different intervention types 
with different facilitators.  
Coherent data across the 
studies. 






Difficulty of applying when the 







1 study of moderate quality 





Difficulties of being in the 
patients’ home 
Peters (2011) Low 
confidence 
1 study of moderate quality 




Ride it out (when the intervention 
isn’t addressing needs and both 
parties know it) 
Peters (2011) Moderate 
confidence 
2 studies, both of moderate 
quality, both including thick 
data.  Evidence came from 
different intervention types 
with different facilitators.  
Coherent data across the 
studies. 
Nothing new (HPs felt they were 
already doing it) 
Dowrick 
(2008) 
Barriers – from the perspective of health professionals why patients didn’t want behavioural interventions / or 
couldn’t engage with them, or barriers to delivery of the intervention 
Resource 
constraints 





4 studies, all of moderate 
quality, including thick data.  





intervention types with 
different facilitators.  Coherent 
data across the studies. 









Lack of clarity on service 
provision for PPS 
Lewis (2013) 










4 studies, one high quality, 
three of moderate quality.  All 
three including thick data. 
Evidence came from different 
intervention types with 
different facilitators.  Coherent 
data across the studies. Patients benefit from their 




Patients have an agenda (e.g. 
target the locum) / Patients’ pre – 




Patients’ beliefs about not being 
able to do physical activity. 
Lewis (2013) 
Patients resistance to intervention 
/ Patients didn’t want to engage 













1 study of moderate quality 
with thick data.* 
GPs prior expectations of patients Dowrick 
(2008) 
GPs mood Dowrick 
(2008) 








2 studies, one of high quality, 
one of moderate quality.  Both 
including thick data.  Evidence 
came from different 
intervention types with 
different facilitators.  Coherent 
data across the studies. 
Patients’ physical difficulties 
were barriers to attendance and 
adherence 
Lewis (2013) 
Other factors Not knowing if it is actually 





1 study of moderate quality 
with thick data.* 














3 studies, one of high quality, 
two of moderate quality, 
including thick data.  Evidence 
came from different 
intervention types with 
different facilitators.  Coherent 
data across the studies. 





*Where only one study relates to a finding it is not possible to assess whether the finding would remain across other 
settings or assesses the coherence of the finding. 
**Thick data describes observed social actions and assigns purpose and intentionality to these actions, by way of a clear 
description of the context. Thin data can be regarded as superficial and does not explore underlying meanings. 
 
Confidence in each review finding was judged as high: It is highly likely that the review finding is a reasonable 
representation of the phenomenon of interest; moderate: It is likely that the review finding is a reasonable representation 
of the phenomenon of interest; low: It is possible that the review finding is a reasonable representation of the 
phenomenon of interest; or very low: it is not clear whether the review finding is a reasonable representation of the 
phenomenon of interest.   
 
 
